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THE EFFECTS OF CANCER TREATMENT-INDUCED BONE LOSS ON 
MORPHOLOGICAL SEX ASSESSMENT 
KALAN LEIGH JASNY 
ABSTRACT 
 Cancer is currently the second most common cause of death in the U.S. with over 
600,000 people expected to die from cancer this year alone. The diagnosis of cancer 
steadily increased through most of the 20th century due to a rise in tobacco usage, causing 
a relatively recent growth in cancer research. In the past several decades, treatments for 
cancer have been rapidly changing and advancing, and it is vital to understand how these 
medications affect the human skeleton. Presently, little research has been conducted on 
how medications alter the human skeleton and impact the biological profile. One of the 
primary side effects of drug and radiation-based treatments for a neoplasm is cancer 
treatment-induced bone loss (CTIBL), which may impact the expression of sexual 
dimorphism in morphological traits. It is hypothesized that CTIBL would decrease the 
robusticity of sexually dimorphic nonmetric traits and skew the ordinal scores towards 
gracile.  
 A total of 178 individuals with documented cancer and/or treatment and 178 
individuals without documented cancer from the William M. Bass Donated Skeletal 
Collection at the University of Tennessee, Knoxville, were assessed following 
conventional sex assessment standards for the skull and os coxa. These methods 
presented by Buikstra and Ubelaker (1994), Klales et al. (2012), and Walker (2005) were 
applied to the os coxa and Walker’s (2008) method for the skull. The individuals ranged 
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in age from 26 to 97 years and included 350 European Americans, two African 
Americans, one Asian/Polynesian, and three Native Americans. The control group was 
designed to parallel the experimental group by demographic information including sex, 
ancestry, and age-at-death. The experimental group was also subdivided into two groups 
that included individuals that underwent chemotherapy and/or radiation (drug subgroup) 
and individuals who only underwent surgery as a form of treatment (surgery subgroup). 
Thirty-six randomly selected individuals were also rescored to test for intraobserver 
agreement. 
 IBM’s Statistical Package for Social Sciences (SPSS) was used to calculate Chi-
Square, ANOVA, ANCOVA, and Cohen’s Kappa analyses. The Chi-Square and 
ANOVA analyses were used to determine if there was any statistically significant 
relationship between cancer treatment status and the scores of the morphological traits. 
The results indicated no significant relationship between cancer treatment status and the 
trait scores (p > 0.05) for all analyses except for the Chi-square analysis of the glabella 
for females in the pooled sample (p=0.047) and the ANOVA analysis of the ventral arc in 
the surgery group when sex was not considered (p=0.010). It is possible that these traits 
are affected by cancer treatment status. However, it is more likely that these results were 
due to natural variation between the control and experimental groups.   
Intraobserver agreement was calculated using Cohen’s Kappa analysis. 
Intraobserver agreement ranged from fair to substantial with most traits indicating 
moderate intraobserver agreement. Some possible confounders of the study include the 
unknown duration of cancer treatments, the use of a history of cancer as a proxy for 
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cancer treatment, not knowing when the individual underwent cancer treatment before 
death, and the assumption that the individuals included in the sample were accurately 
documented. Cancer Treatment-Induced Bone Loss may only affect bone mineral density 
as opposed to the expression of sexually dimorphic traits as many of these visually 
assessed traits are sites of muscle attachments. Though CTIBL does not appear to affect 
morphological sex assessment, further research should be conducted on the possible 
effects of CTIBL for other components of the biological profile.  
   viii 
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CHAPTER 1: INTRODUCTION 
 According to the American Cancer Society (2017) approximately 1,688,780 
individuals will be diagnosed with cancer this year. Cancer is the second leading cause of 
death in the U.S., and approximately 15.5 million people are currently living with a 
history of cancer (American Cancer Society 2017; Maramaldi et al. 2008). Through most 
of the 20th century, cancer deaths have steadily increased. This has been mainly due to the 
increase in tobacco usage, which has been linked to many different forms of cancer. This 
growth initiated a similar rise in cancer research and overall improvements in treatments 
and interventions. The most common forms of cancer today are breast, prostate, lung and 
colorectal cancer, which are all generally treated with therapies such as radiation therapy, 
chemotherapy and hormone therapy (American Cancer Society 2017). According to 
D’Oronzo et al. (2015), the most frequently used forms of cancer treatment are 
recognized as causing a condition known as cancer treatment-induced bone loss (CTIBL), 
which results in the decrease of osteoblastic or bone-forming activity and an increase in 
osteoclastic or bone resorption activity. The imbalance of the osteoblastic-osteoclastic 
relationship results in the net loss of bone material, which then becomes highly fragile 
and susceptible to fracturing (Michaud and Goodin 2006) and may alter the shape and 
appearance of bone. 
 Creating a biological profile that consists of sex, age, ancestry, and stature 
requires a forensic anthropologist to analyze human skeletal remains, while thoroughly 
understanding the myriad factors that can alter bone. Sex is a vital component of the 
biological profile as the assessment of sex can shorten the list of decedents when 
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attempting to identify an individual from their skeletal remains. The sex assessment 
techniques include metric and nonmetric or morphological approaches. Metric techniques 
utilize the measurements of numerous elements in the body such as areas of the os coxa, 
skull and lengths or diameters of the long bones. Nonmetric or morphometric analyses 
examine either the overall robustness of sexually dimorphic elements or the size and 
shape of specific traits on these sexually dimorphic elements (Krogman 1962). Due to the 
establishment of the Daubert criteria in 1993, Forensic Anthropologists are moving 
towards the use of less subjective methods that do not rely solely on the experience of the 
observer (Christensen and Crowder 2009; Krogman 1962). The Daubert criteria were 
established in 1993 following the court case of Daubert v. Merrell Dow Pharmaceuticals, 
Inc. (Christensen and Crowder 2009; Dyer and McCann 2000). The criteria established 
what kind of evidence is admissible in court. Since the instillation of the Daubert criteria, 
all evidence submitted in court, including the methodologies utilized in forensic 
anthropology, must be scientifically valid, reproducible, and commonly accepted among 
the appropriate scientific community by its publication in peer-reviewed journals. This 
means that the techniques used in forensic anthropology needed to have strong statistical 
backing with known accuracy and error rates. This change in evidence criteria led to a 
reevaluation of the methods commonly performed in forensic anthropology (Dirkmaat et 
al. 2008).  
 Many validation studies of old techniques have been conducted, and it has been 
generally accepted that less subjective techniques need to meet the new evidentiary 
criteria. This led to a massive development of metric-based methods that did not rely on 
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the experience of the observer to be correctly performed (Christensen and Crowder 2009; 
Dirkmaat et al. 2008). However, metric methods can be time consuming and often 
require more specialized equipment. Nonmetric techniques can be conducted relatively 
quickly and require only the observer and the remains (Walker 2008). This is why 
morphological techniques to determine sex still prevail in forensic anthropology 
(Stevenson et al. 2009). New technologies are also being used to make both metric and 
morphological methods more accurate. For example, CT scans and 3D imaging studies 
have been conducted to create methods that visually determine sex from 3D models 
(Decker et al. 2011). However, the necessary computing equipment is very expensive and 
therefore, not accessible to everyone. 
 Since the Daubert decision took effect, significant research has focused on 
establishing accuracy and error rates for these morphologically based techniques so that 
they can remain admissible in court. Some techniques have been found to be highly 
accurate on their own. For example, Walker (2008) conducted a study that used 
discriminant function analyses to provide statistical backing to the common technique 
presented in Buikstra and Ubelaker (1994) for determining sex from five sexually 
dimorphic traits found on the skull. Other researchers have determined that other 
techniques needed to be updated. In particular, Klales et al. (2012) examined the sex 
assessment technique introduced by Phenice (1969) that uses three traits found in the 
pubic region of the os coxa to determine sex.  
 The two skeletal elements that have been traditionally believed to be the most 
sexually dimorphic of the body are the os coxa and skull (Graw et al. 1999; Klales et al. 
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2012; Pinto et al. 2016; Walker 2008). The os coxa is the most sexually dimorphic 
element in the body due to developmental differences between the sexes. As females are 
capable of birth, their os coxae are designed to handle the stresses and needs of childbirth 
by having larger pelvic inlets and the ability to expand the attachment at the pubic 
symphyses during labor (Coleman 1969; Klales et al. 2012). The five traits most often 
examined in the os coxa arise due to developmental differences both in the os coxa itself 
and through differences in muscle development (Coleman 1969). The five traits 
examined in the skull are generally sexually dimorphic due to the fact that several of 
them are sites of significant muscle attachments. The differences in robusticity of these 
muscles between the sexes leads to differences in robusticity of the underlying bone 
(Djukic et al. 2015; Walker 2008). Postcranial elements can also be used to determine sex 
through metric analyses. In fact, these methods are more accurate than morphological 
assessments of the skull (Spradley and Jantz 2011). However, these methods are metric 
based, and therefore, not utilized in this study. 
 The techniques utilized by forensic anthropologists must be scientifically sound as 
they are occasionally used as evidence in a court of law. Therefore, it is vital that all 
possible confounders of these methods are thoroughly researched and understood in a 
forensic context. However, very little research has been conducted on how 
pharmaceutical drugs can affect human skeletal anatomy and potentially alter the 
biological profile. The little research that has been conducted has mainly focused on the 
effects of substance abuse on the biological profile. Taylor (2000) conducted her 
dissertation on the effects of heroin, cocaine, alcohol, and intravenous drug usage on age-
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at-death estimations from the sternal end of the 4th rib. Taylor (2000) determined that 
these drugs did have an effect on age-at-death estimation, though she found that these 
drugs both caused over- and under-estimation of ages-at-death. Though it was not the 
main topic of her dissertation, Hartnett (2007) discusses the effects of substance abuse on 
age-at-death estimations from the pubic symphysis and sternal end of the 4th rib. Hartnett 
(2007) determined that substance abuse has no statistically significant effect on age-at-
death estimation, but she did note that when an individual was assigned to an incorrect 
age category, they usually had a history of substance abuse. Based on this research, 
which has shown that drugs can affect the biological profile, it is also possible that other 
medications can affect the biological profile.  
 Over the past several decades there has been an increase in available treatments 
for prevalent diseases such as cancer, and as a forensic science, forensic anthropology 
must keep pace with this modernization of medicine (Michaud and Gooding 2006). It is 
known that many of the primary cancer treatments can affect the morphology of the 
skeleton, and research must be conducted to determine how these treatments affect the 
standard methods used for creating a biological profile (D’Oronzo et al. 2015). 
  Cancer treatment-induced bone loss is a serious condition that could potentially 
affect as many as 15.5 million individuals in the U.S. today (American Cancer Society 
2017). If the remains from these individuals were to be found and examined in a forensic 
context, the forensic anthropologist must be able to understand how CTIBL could affect 
the morphology of the skeleton. Cancer treatment-induced bone loss often presents as 
osteoporosis, which is a bone disease resulting in the clinical manifestation of reduced 
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bone mineral density (BMD) and is associated with increased age (D’Oronzo et al. 2015). 
However, forensic anthropologists are often tasked with identifying the remains of 
individuals from all age ranges, and cancer can affect an individual at any age. Therefore, 
a younger individual could present with osteoporosis due to CTIBL and without 
knowledge of how CTIBL alters bone, the sex assigned to the remains may be inaccurate. 
Similarly, it is possible that CTIBL may also cause a decrease in the size and robusticity 
of sexually dimorphic traits that are used in sex estimation. If cancer treatment drugs 
induce a decrease in bone mineral density, then the expression of morphological sex 
indicators may be affected. Therefore, if CTIBL results in a decrease in the robusticity of 
sexually dimorphic traits, then the morphological sex estimation of individuals who have 
received cancer treatment will be biased towards females. However, to date, little is 
known about the precise effects of CTIBL on bone and how it can impact determining the 
sex of human remains. 
 Sex is one of the most important components of the biological profile, and any 
possible influences on the standard techniques utilized in forensic anthropology must be 
thoroughly understood. The goal of this study was to determine if CTIBL, which is a 
major side effect of almost all cancer treatments, affects the robusticity of sexually 
dimorphic traits in the os coxa and skull, and therefore, affects the assessment of sex. 
This chapter introduces the biological profile and its importance in Forensic 
Anthropology. It also discusses what cancer treatment-induced bone loss is and how it 
may be relevant to the employment of the standard morphological techniques that are 
used to assess sex in Forensic Anthropology. Chapter 2 reviews the causes of CTIBL, 
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more thoroughly explains the use of sexually dimorphic traits to determine sex in forensic 
anthropology, and more distinctly links the two. Chapter 3 discusses the sample utilized 
in this study, what sexually dimorphic traits were utilized and how they were scored, and 
what statistical analyses were employed to assess the possible connection between the 
cancer treatment status of the individuals and the trait scores. This chapter also reveals 
how intraobserver agreement was determined to ensure that all results from the study 
were based on statistically determined relationships as opposed to chance or error on the 
part of the observer. Chapter 4 presents the results of the statistical analyses conducted 
including Chi-Square, ANOVA, ANCOVA, and Cohen’s Kappa analyses. Chapter 5 
discusses the significance of the results presented in Chapter 4 and the observed effects of 
CTIBL on morphological sex assessment. Lastly, Chapter 6 presents conclusions from 
the research and how the research should be expanded in the future.  
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CHAPTER 2: PREVIOUS RESEARCH 
Introduction 
 The U.S. is becoming heavily dependent on pharmaceutical treatments (Stimmel 
1985), and many of these medications can affect human skeletal anatomy when used 
long-term (Hudec and Camacho 2013). However, very little human osteology research 
has been conducted on how the long-term use of medications affects human skeletal 
anatomy. The majority of research, has focused on the effects of substance abuse on the 
biological profile (Hartnett 2007; Taylor 2000). For example, Taylor’s (2000) dissertation 
examined the effects of substance abuse including cocaine, heroin, intravenous drugs, and 
alcohol on the reliability and accuracy of using the sternal end of the 4th rib to determine 
age-at-death. She determined that substance abuse did affect the reliability and accuracy 
of the method. This was attributed to the fact that chronic drug abuse is linked to thoracic 
disease, which potentially impacts the morphology of the sternal rib ends. This was found 
to be the case as substance abuse causes both an overestimation and underestimation of 
the age of the individual (Taylor 2000). Therefore, more research into this topic must be 
conducted. 
  Several medications are known to cause decreased bone mineral density (BMD) 
including but not limited to Glucocorticoids, antiepileptics, heparin, immunosuppresants, 
and diabetes medications (Chandran 2017; Hudec and Camacho 2013). These drugs are 
all associated with the onset of osteoporosis, which is a disease resulting in an overall 
decrease in BMD that can lead to increased fractures. Osteoporosis is known to affect 4 
to 6 million women and 1 to 2 million men in the U.S. (Hudec and Camacho 2013).  
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 Of these medications and treatments that can cause osteoporosis, some of the 
most pervasively prescribed are cancer medications and treatments. According to the 
American Cancer Society (2017), as of January 2016 over 15.5 million Americans were 
living with a history of cancer. Further, around 600,920 individuals are expected to die 
from cancer in the U.S. this year alone. Even with the advancement of treatments and the 
increase in knowledge of risk factors for cancer the survival rates are still only 68% for 
European Americans and 61% for African Americans (American Cancer Society 2017).  
Cancer 
 Cancer is a disease that develops when abnormal cells grow out of control and 
proliferate in the body. The spread of cancer cells to other parts of the body is known as 
metastasis. Oncogenes and tumor suppressor genes are the two main genes associated 
with the creation of cancer cells (Ecsedy and Hunter 2008). Oncogenes promote the 
growth of pathways while tumor suppressor genes either repair or limit the growth of 
pathways. The creation of cancer cells is associated with mutations that drive the 
abnormal cells to grow and proliferate at the expense of the normal cells around it. 
However, it takes considerable time for these mutations to affect cells. Therefore, cancer 
is usually a later-in-life disease, and it has become more common as life expectancy has 
increased (Ecsedy and Hunter 2008; Gluckman et al. 2016).  
 Abnormal cells most commonly occur when tumor suppressor genes undergo a 
mutation that limits their function. This mutation then drives the cell to multiply and 
outcompete the local, normal cells (Gluckman et al. 2016). As these originator cells 
expand, other cells are created that are sub-clones of the original. These sub-clones have 
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a slightly different genetic makeup to the original cells and only contain a portion of the 
original mutation. Having cells with slightly different mutations allows these sub-clones 
to support vascularization of the tumor, while breaking down barriers that may keep the 
cancer cells from expanding and prevent the cells from being detected and destroyed by 
the immune system. These cancer cells then proliferate to form a tumor in the body. The 
tumor mainly consists of these primary cancer cells. However, it also consists of non-
cancer cells such as epithelial cells and fibroblasts, which makeup the tumor stroma.  
 Cancer cells contain great genetic diversity due to the proliferation of many 
different mutations in the sub-clones. This is the reason that many different treatments 
exist for cancer (Gluckman et al. 2016). Some of the cancer cells may be more or less 
resistant to different types of treatment. This is especially important in chemotherapy 
treatment. Some of the cancer cells may be resistant to certain types of chemotherapy 
depending on the mutations they possess. This is why cancer can be so difficult to 
completely eliminate in the body. If there are cells that are resistant to the chemotherapy 
treatment being used then the cancer may still return after treatment even if most of the 
cells were destroyed during the initial treatment.  
Cancer Treatments 
 There are many different types of treatments that can be used to target and 
eliminate cancer in the body (Jones 2015). Each one focuses on a different way of 
destroying the cancer cells. The major forms of cancer treatment include chemotherapy, 
radiation therapy, surgery, biological therapy, targeted therapies, hyperthermia, lasers, 
photodynamic therapy, cancer vaccines, and alternative cancer therapies. These 
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treatments range from prescription drugs to lasers to eradicate cancer cells in the body. 
Each treatment has its own benefits, reasons for usage, and consequences. The most 
commonly used forms of treatment currently are chemotherapy, radiation therapy, 
biological therapy, and surgery. 
 Chemotherapy involves the use of drugs to destroy cancer cells. These drugs can 
stop the growth of cancer cells, which is why it is often used in conjunction with surgery, 
radiation therapy or biological therapy. Chemotherapy is often used before surgery to 
make a tumor smaller. This is known as neo-adjuvant chemotherapy (Jones 2015). It can 
also be used after surgery or radiation treatment to ensure the complete eradication of the 
cancer cells. This is known as adjuvant chemotherapy. There are many different types of 
chemotherapy drugs that can be taken a variety of ways including by injection, intra-
arterial, and intravenously. The type of chemotherapy given and the way it is given 
depends on the type of cancer. Chemotherapy can have severe side effects though 
because the drugs can harm healthy cells as well as the cancer cells. This is why hair loss 
is a common symptom of chemotherapy.  
 Radiation therapy involves the use of radiation to kill and stop the spread of 
cancer cells. Radiation therapy can either be external beam or internal beam. External 
beam radiation therapy is when a machine is directed at the patient and radiation is aimed 
at the part of the body where the cancer cells are consolidated (Jones 2015). Internal 
beam radiation therapy is when radiation is placed inside the body of the patient near the 
cancer cells. Radiation therapy is a very common form of treatment. In fact, about 60% of 
patients diagnosed with cancer receive radiation therapy at some point. However, 
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radiation therapy does not kill cancer cells right away. It can take days or weeks for 
cancer cells to begin to die off, and they will continue to die even after treatment has 
stopped. Unfortunately, radiation therapy can also kill healthy cells. This is why radiation 
treatments should be spread out as much as possible and as low a dose as possible should 
be used.  
 Biological therapy uses living organisms to treat diseases. This can include 
vaccines or bacteria, which stimulate the body’s immune response. This is known as 
immunotherapy or biological response modifier therapy (Jones 2015). This type of 
treatment does not target the cancer cells directly but causes the body’s immune system 
to respond in a way that will destroy cancer cells. There are also forms of biological 
therapy that do target cancer cells directly using genetic material or antibodies. The 
biological therapies that directly affect the cancer cells are known as targeted therapies. 
Biological therapies can be used both treat cancer and to alleviate the side effects from 
other cancer treatments. 
 Many of the other therapies that can be used in cancer treatment are not placed 
inside the body. These treatments include laser therapy, hyperthermia therapy, and 
photodynamic therapy (Jones 2015). These therapies involve the use of external devices 
and stimuli to affect the cancer cells. For example, hyperthermia treatment involves the 
heating of the area where the cancer cells are consolidated to around 113°F. It is known 
that high heat can damage cancer cells. Lasers are often used during surgery when very 
precise pieces of skin must be removed from the body. This is very useful in the 
treatment of very localized external cancers such as skin cancer. 
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 Alternative or complimentary therapies are treatments that are used either instead 
of or with cancer treatments. Together these are known as complementary and alternative 
medicines (CAM). They are often used to manage the symptoms of cancer and side 
effects of the medical treatments for cancer (Jones 2015). These times of treatments often 
range from acupuncture to spiritual healing to botanicals and herbs (Maramaldi et al. 
2008). The most commonly reported CAM treatments utilized are prayer and spiritual 
practice, relaxation, faith and spiritual healing, and nutritional supplements and vitamins. 
Generally, around 4 out of 10 adults use CAM therapies in their daily lives (Jones 2015).  
 Cancer is a significant topic of research currently as it is the second leading cause 
of death in the U.S. (American Cancer Society 2017). Treatments are constantly being 
created and/or improved. However, many of these treatments do come with long term and 
even dangerous consequences. These side effects can range from temporary hair loss to 
vomiting to the loss of bone mineral density leading to an increased risk of fractures. This 
last side effect, the loss of bone mineral density is an especially pervasive side effect of 
many of the different cancer therapies that are commonly utilized in a clinical setting. 
This loss of bone mineral density as a side effect of cancer treatment is known as cancer 
treatment-induced bone loss (CTIBL) (Michaud and Goodin 2006).   
Cancer Treatment-Induced Bone Loss 
 Cancer treatment-induced bone loss is a well-documented side effect of many of 
the cancer treatment therapies available today. Hormone therapies, chemotherapy, 
radiation therapies and chemical castration are all known to cause CTIBL either directly 
or indirectly (Michaud and Goodin 2006; Taxel and Mirza 2009). According to the 
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American Cancer Society (2017) the most commonly diagnosed forms of cancer are 
breast cancer in women and prostate cancer in men. Women who have been diagnosed 
with breast cancer often receive chemotherapy, surgery and/or hormone therapy 
(American Cancer Society 2017; Hadji 2015). Many of the drugs used to treat women 
diagnosed with breast cancer such as methotrexate, doxorubicin, and cyclophosphamide 
can lead to a condition known as hypogonadism (D’Oronzo et al. 2015; Rana et al. 
2013). Hypogonadism occurs when these drugs damage the ovaries, which decreases the 
number of secondary ovarian follicles (D’Oronzo et al. 2015). Of premenopausal women 
who receive chemotherapy for breast cancer, 63-96% undergo premature menopause 
within one year of starting treatment. Men who are diagnosed with prostate cancer are 
often treated with androgen deprivation therapy (ADT), which also decreases gonadal 
hormone levels and results in hypogonadism (Michaud and Goodin 2006). Gonadal 
hormones such as estrogen are known to influence bone metabolism, and when estrogen 
levels are decreased in women who receive chemotherapy and men who undergo ADT, 
osteoclastic activity increases and results in more bone resorption than bone formation 
(Coleman et al. 2013).  
 Normal bone metabolism involves different cell types working in consort to 
resorb and replace bone throughout an individual’s lifetime. Osteoblasts are cells that 
produce osteoid or pre-bone tissue and are involved in the creation of bone. Osteoclasts 
are cells that resorb bone material. Together osteoblasts and osteoclasts continuously 
remodel the human skeleton so that it can maintain its strength (White et al. 2012). 
However, the human skeleton is also highly adaptive. Bone will also remodel due to 
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consistent biomechanical stresses on the skeleton. If excess strain is continuously placed 
on bone, the area affected will remodel itself so that it can more effectively withstand and 
accommodate that load. This is often seen in athletes that use specific parts of their 
bodies. For example, professional tennis players often have increased bone mass in their 
racket arm as the bone has remodeled to account for the increased biomechanical stresses 
experienced by that arm. The balance between osteoclastic and osteoblastic activity both 
maintains bone structure and adapts to the stresses of life (Currey 2002). However, this 
balance can be interrupted by many factors including age, disease, and chemicals. 
 Cancer treatment-induced bone loss is essentially chemically induced 
osteoporosis. Osteoporosis is an age-related degenerative disease that is defined as “a 
skeletal disorder characterized by compromised bone strength and that predisposes to 
increased risk of fracture” (Nanes and Kallen 2014:439 Bone strength is a combination of 
bone density and bone quality. Bone quality is difficult to measure clinically as it is a 
combination of factors such as bone architecture and micro-damage accumulation. Bone 
density can be measured using dual-energy x-ray absorptiometry (DXA) (Nanes and 
Kallen 2014). Dual-energy x-ray absorptiometry passes photons through the bone, which 
measures density by determining how many photons were able to pass through the bone 
(Adams 2003; Jergas 1998). Osteoporosis is not clinically diagnosed until fragility 
fractures occur. The most common fragility fractures due to BMD loss are vertebral 
fractures, femoral neck fractures, and “Colles fractures” of the distal radius. The loss of 
BMD can also be diagnosed as osteopenia, which is defined as the loss of BMD with a 
lower risk of fragility fractures (Jergas 1998; Nanes and Kallen 2014). Osteoporosis 
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generally affects trabecular bone but can also cause damage to cortical bone as well 
(Adams 2003; Khosla and Pacifici 2013; Pietschmann et al. 2003). 
 Osteoporosis is known to affect 34 million individuals in the U.S. annually with 1 
out of 2 women in the Western World projected to experience a fracture after the age of 
50 (Adams 2003; Nanes and Kallen 2014). After about 30 years of age a gradual decrease 
in BMD occurs for both males and females. However, there is an accelerated loss of 
BMD for women once they reach menopause. Post-menopausal bone loss in women 
gradually recedes until older men and post-menopausal women lose BMD at the same 
rate. Osteoporosis can be treated with estrogen replacement therapy. However, only 
around 4-6% of women who are affected by osteoporosis are actually diagnosed and 
treated (Nanes and Kallen 2014).   
 Women can also receive and be affected by different forms of chemotherapy 
based on their pre- or post-menopausal status. Menopause is defined as the “cessation of 
spontaneous menses for 12 months” (Takahashi and Johnson 2015:521). On average, 
women in the U.S. experience menopause at age 51. It is a period where the development 
of oocytes ceases completely and permanently. Oocytes secrete inhibin B, which 
regulates the ovarian negative feedback of follicle-stimulating hormone (FSH) 
production. With the decrease in available oocytes, there is a subsequent increase in FSH 
production. This leads to an increase in follicular recruitment, and therefore, an increase 
in follicular loss. This overall loss in follicles causes a decrease in the production of 
estrogen, resulting in overall lower levels of estrogen in post-menopausal women. Post-
menopausal women with lower estrogen levels are therefore more susceptible to 
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osteoporosis and fragility fractures than women who are pre-menopausal (Takahashi and 
Johnson 2015; Wright and Guise 2014). 
 Women who are post-menopausal are already more susceptible to osteoporosis 
and have decreased BMD compared to women who are pre-menopausal. Therefore, they 
are also more susceptible to CTIBL as a side effect of cancer treatments and are more 
impacted by CTIBL. Women who are post-menopausal may also receive different 
chemotherapy treatments than women who are pre-menopausal. Aromatase inhibitors are 
a common form of chemotherapy treatment for hormone responsive breast cancer in post-
menopausal women (Bošković et al. 2017). Aromatase inhibitors block peripheral 
estrogen production, which is designed to stop the development of cancer related cells. 
However, post-menopausal women who receive aromatase inhibitors such as anastrazole 
often experience bone loss at more than twice the rate of menopause-induced bone loss 
alone (Lipton et al. 2013).   
 Normal bone metabolism and repair is precipitated by osteoblastic and 
osteoclastic activity. Osteoclasts resorb bone that is either damaged or old. Osteoblasts 
are responsible for laying down new bone in place of the old bone that was resorbed. 
Overall these two processes work together resulting in no net loss or gain of bone 
(Michaud and Goodin 2006). Natural bone remodeling and repair occurs throughout life 
in response to biomechanical stresses and stimuli (Avelar et al. 2017). However, when 
osteoclastic and osteoblastic activities in bone are no longer synchronized, which is what 
occurs with CTIBL, a net loss of bone mineral density (BMD) ensues (Michaud and 
Goodin 2006). Further, CTIBL often presents as osteoporosis, which simply refers to the 
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general decrease of BMD and can create a fertile niche for cancer cells within bone 
leading to more cancer-induced metastatic growths (D’Oronzo et al. 2015). 
 It is common for cancer to metastasize to bone especially in prostate and breast 
cancer patients. These patients account for 80% of cases involving cancer-induced bone 
metastatic growths (Hensel and Thalmann 2016). Osteolytic cancer cells can affect 
growth factors that cause osteoblasts to release Receptor Activator of Nuclear Factor κ B-
Ligand (RANKL), which is a surface cell receptor protein. RANKL then binds to 
osteoclast progenitor cells leading to osteoclastogenesis. This increase in osteoclasts 
leads to an increase in bone resorption. The resorption of bone releases ions such as 
calcium that actually fuel the growth of cancer cells (Hensel and Thalmann 2016). 
CTIBL is often caused by an increase in osteoclastic activity. This excess osteoclastic 
activity also can encourage cancer cell growth, which leads to an increase in bone 
metastatic growths (D’Oronzo et al. 2015; Wright and Guise 2014). Figure 2.1 is an 
example of metastatic cancer growth on the cranium observed in the UTK sample.        
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Figure 2.1: Metastasized cancer on Cranium (UT62-11). 
 Cancer treatment drugs can also directly affect osteoblastic or osteoclastic 
activity. Methotrexate is known to directly increase osteoclastic activity and decrease 
osteoblast formation through the inhibition of DNA synthesis. Other drugs such as 
Cyclophosphamide inhibits the ability of pre-osteoblasts and osteoclast cells to divide. 
Many chemotherapy drugs are known to decrease the osteoprogenitor cells in the body 
that are the precursors to osteoblasts and osteoclasts. High doses of Ifosfamide are known 
to lead to renal tubular nephrotoxicity, which in turn leads to hypophosphatemia. 
Hypophosphatemia adversely affects the mineralization and demineralization of bone, 
which leads to a decrease in proper bone formation (Michaud and Goodin 2006).  
 Even surgery on its own can result in CTIBL as a side effect. Individuals with 
early-stage gastric carcinoma often undergo a gastrectomy to remove the part of the 
gastric system that is affected by the cancer. This surgery removes the cancer but can also 
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result in hypocalcemia and low Vitamin D levels. This is due to a patient’s already 
limited dairy intake, and the surgery can disrupt the body’s ability to properly absorb 
nutrients. All of these adverse side effects can also lead to a reduced BMD and an 
increased risk of fractures (Jones 2015).  
Morphological Sex Assessment 
 Many of the methods used by forensic anthropologists today to determine the sex 
of skeletal remains rely on visually determined sexually dimorphic morphological traits. 
However, since the institution of the Daubert criteria in 1993, forensic anthropology has 
been moving away from subjective methods that rely on observer experience. This has 
resulted in the use of more metric-based methods (Christensen and Crowder 2009; 
Krogman 1962). However, metric methods often are more time consuming and require 
special equipment. Nonmetric methods that examine the size and shape of sexually 
dimorphic traits only require the observer and the skeletal element. This is why these 
methods continue to prevail in forensic anthropology, as they are easy to use (Walker 
2008). In order to ensure that these methods are admissible in court, many have either 
been revised or reexamined to provide statistical backing with accuracy and error rates 
(Thomas et al. 2016). For example, Klales et al. (2012) recently updated the Phenice 
(1969) method, a morphological method for assessing sex using three traits of the os 
coxa, by providing statistical support and changing the ordinal scoring so that it was more 
in line with other techniques that use ordinal scores. Walker (2008) evaluated the 
morphological techniques used to determine sex from the skull as presented in Buikstra 
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and Ubelaker (1994) and created discriminant function equations so that the probabilities 
for the sex could be easily calculated.  
 The most common techniques used to determine sex morphologically involve 
examinations of the os coxae and skull (Graw et al. 1999; Pinto et al. 2016; Walker 
2008). The os coxae are the most sexually dimorphic elements of the skeleton due to 
differences in reproduction and are, therefore, the most useful skeletal elements in the 
determination of sex. The morphological methods used today for the os coxae are derived 
from the technique created by Phenice (1969) that is performed by examining three 
features on the subpubic region of the os coxa. The presence of a feature indicates female 
and the absence of that feature indicates male. The first feature is the ventral arc, which is 
described as a small ridge of bone that extends inferiorly from the pubic crest to the 
subpubic concavity. The second feature is a lateral recurve known as the subpubic 
concavity, which is visible just inferior to the pubic symphysis. The third landmark 
described by Phenice is a ridge on the medial aspect of the ischiopubic ramus. An os coxa 
that presents with a ridge in this location is defined as female while a broad, flat surface 
is considered male.  
 Klales et al. (2012) reevaluated Phenice’s (1969) work in order to increase its 
accuracy, update the scoring system to match contemporary techniques and explain why 
these sexually dimorphic traits exist. Klales et al. (2012) updated the scoring system from 
Phenice’s presence or absence to an ordinal scoring system of 1 to 5. The scores range 
from one indicating hyperfeminine to five indicating hypermasculine. These ordinal 
scores were created because they are more in line with the ordinal scoring systems of 
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other morphological sex assessment techniques. According to Klales et al. (2012), the 
differences between males and females in these three subpubic traits can be explained by 
developmental differences and differences in the orientation of muscle attachments. The 
ventral arc is larger and far more laterally oriented in females. This is because the area is 
an attachment site for the adductor muscles including gracilis, adductor magnus and 
adductor brevis (Anderson 1990; Klales et al. 2012). These three muscles attach on the 
anterior face of the pubic region in both males and females. However, in females the 
muscle attachments are placed far more laterally than in males. This creates the distinct 
ventral arc found in females but also explains why a much smaller and medially placed 
ridge of bone can also be seen in males. This small ridge of bone in males is why Klales 
et al. (2012) created a more expansive scoring system for this trait.  
 The subpubic contour is more complex in its creation, and the sexual dimorphism 
of this area arises from developmental changes of the os coxa as a whole and from more 
localized regions of the os coxa (Coleman 1969). Anderson (1990) argues that the more 
concave shape of the subpubic contour in females is created due to the lengthening of the 
os coxa during development to allow for a larger pelvic inlet, which is vital in childbirth. 
Coleman (1969) argued that it is more than just the elongation of the os coxa that creates 
the shape of the subpubic contour. He states that the most important factors in the 
development of the subpubic angle are the differences in the development of the ischial 
tuberosity and the medial border of the ischiopubic ramus. According to Coleman (1969) 
the ischial tuberosity moves more inferiorly and laterally in females, where as it only 
moves inferiorly in males. Additionally, the infero-medial margin of the ischiopubic 
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ramus moves inferior and laterally in females, whereas the medial margin only moves 
inferiorly in males. Coleman (1969) also states that these differences in lateral movement 
of specific regions of the os coxa are what cause sexual dimorphism in the subpubic 
contour.  
 Very little research has been conducted on why sexual dimorphism exists on the 
ischiopubic ramus. However, Klales et al. (2012) postulates that the narrower form of the 
ischiopubic ramus in females may be due to the lengthening of this area during 
development. The inferior and lateral movements of the ischiopubic ramus ridge 
described by Coleman (1969) may also play a part in the sexual dimorphism of this area. 
Sexual dimorphism has been shown to manifest in this area and can be utilized to 
accurately determine sex in conjunction with other traits of the os coxa. However, more 
research must be conducted in order to understand why these sexual differences exist 
(Klales et al. 2012; Phenice 1969).  
 Subsequent to Phenice (1969), other researchers have either validated or updated 
his work and found that other characteristics of the os coxa are needed to increase the 
accuracy of determining sex (Buikstra and Ubelaker 1994; Klales et al. 2012; Lewis and 
Garvin 2016; Ubelaker and Volk 2002; Walker 2005). The elements most commonly 
used today include the width of the greater sciatic notch (GSN) and the presence or 
absence of a preauricular sulcus (Buikstra and Ubelaker 1994; Walker 2005). According 
to Walker (2005), the width of the greater sciatic notch can be analyzed to determine sex. 
The sciatic notch is scored on an ordinal scale of 1 to 5, where 1 is considered to be 
female and is the widest form of the notch. A score of 5 is considered to be male and is 
  
  
24 
described as the narrowest form of the notch. The preauricular sulcus is scored on an 
ordinal scale from 0 to 4. A score of 0 indicates an absence of a preauricular sulcus and 
would be categorized as male. The scoring of a 4 indicates a preauricular sulcus that is 
shallow, narrow and smooth walled, which is indicative of a female os coxa (Buikstra and 
Ubelaker 1994). 
 Sexual dimorphism in the greater sciatic notch is very individualized and 
dependent on regional growth of the os coxa. One of the most important factors is the 
growth of the ischial spine. During adolescence, the ischial spine will move more 
laterally in females, which leads to a wider GSN. Also, as individuals go through changes 
in height, the area encompassing the superior arc of the GSN will undergo more 
remodeling resorption leading to a deep GSN. Therefore, this is more often seen in males 
as they undergo larger trunk height growth spurts. Another important area of 
development that influences the GSN is the development of the posterior inferior iliac 
spine (PIIS). As the sacro-iliac joint enlarges in males, the PIIS will continue to grow 
inferior-medially. This maintains a narrow and deep GSN in males while the female GSN 
remains wide because the sacro-iliac joint does not grow as much as in males (Coleman 
1969).  
 Another area of the os coxa analyzed for sex assessment is the preauricular 
sulcus; however, it is not well understood. The pre-auricular sulcus is utilized as a 
sexually dimorphic trait where the presence of a pre-auricular sulcus indicates female. 
However, the ordinal scoring method scores different forms of the pre-auricular sulcus as 
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opposed to presence versus absence (Buikstra and Ubelaker 1994). Neither is the 
development of the pre-auricular sulcus well understood.  
 There is currently debate over how diagnostic the skull is when determining sex, 
and there are those that argue that measurements of the postcrania are more accurate for 
sex estimation (İşcan 2001; Spradley and Jantz 2011). However, there are five 
morphological traits commonly used to assess sex on the skull. Each trait is scored on a 
scale from 1 to 5, with 1 representing the most gracile and smooth form of the trait and 5 
denoting the most robust appearance of the trait. The five landmarks commonly analyzed 
include the nuchal crest, mastoid process, supraorbital margin, glabella and mental 
eminence (Buikstra and Ubelaker 1994; Walker 2008). There are other traits found on the 
skull such as the size of the occipital condyles or the parietal eminences that can be 
analyzed when determining sex (Rogers 2005). However, several studies have found the 
previously listed five are the most accurate characteristics (Buikstra and Ubelaker 1994; 
Walker 2008; Williams and Rogers 2006).  
 Of the five traits of the skull that were scored in this study, most develop 
differently between the sexes due to the fact that they are sites of significant muscle 
attachments. The development of these muscles contributes to the size and shape of the 
trait. This is why the male traits of the skull tend to be larger in size and shape than the 
female traits of the skull. The muscles in the male skull are usually stronger, leading to 
the more robust expression of the male sexually dimorphic traits utilized in the standard 
techniques to determine sex in forensic anthropology (Walker 2008). However, the 
glabella and the supraorbital margins are related to the overall development of the facial 
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skeleton (Graw et al. 1999). Sexual dimorphism in the mandible has also been attributed 
to many different influences such as diet, genetics, and muscle attachments (Alarcón et 
al. 2016).  
 The mastoid process is located on the temporal bone, just inferior and posterior to 
the external auditory meatus. According to Petaros et al. (2015), the mastoid process is a 
significant site of muscle attachment in the cranium and is highly influenced by the 
development of these muscles. The mastoid process is not present at birth and develops 
within the first one to five years of life. Several important muscles attach to the mastoid 
portion of the temporal bone and to the mastoid process itself. These muscles include 
longissimus capitis, splenius capitis, and sternocleidomastoid to name a few. As these 
muscles develop through life they pull downwards on the temporal bone, and as they do, 
the mastoid process is subsequently elongated. The development of the mastoid process 
itself can also affect sexual dimorphism in this area. The mastoid process is hollow and 
mastoid cells are highly variable in growth as this hollow space is developed. This leads 
to large differences between and within the sexes (Petaros et al. 2015).  
 Postcranial elements can also be utilized to assess sex. Spradley and Jantz (2011) 
argue in their study that the postcranial elements may be more reliable determiners of sex 
than the skull. However, determination of sex using the postcranial elements is largely 
based on metric analyses (Buikstra and Ubelaker 1994). This study focused only on 
visually assessed sexually dimorphic morphological traits, and therefore, did not include 
the postcrania other than the os coxae.  
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  There are also several factors that can influence the morphology of sexually 
dimorphic traits. Research conducted by Garvin et al. (2014) statistically analyzed the 
extent to which population affinity and age affect morphological traits on the skull. It was 
determined that these factors can have an impact on the traits used in sex assessment. For 
example, in Walker’s (2008) study on estimating the sex of skulls using discriminant 
function analysis, he determined that the Native American skulls utilized in his study 
presented with more robust morphological traits and less sexual dimorphism compared to 
his American Black and White samples. Clearly, ancestry can affect the morphology of 
the skull. Garvin et al. (2014) compared European American, African American, 
medieval Nubian, and Arikara Native American samples. They also found that population 
affinity was highly influential in determining overall robusticity of the skull. Garvin et al. 
(2014) determined that the modern European American male samples had the most robust 
features out of all of the samples. These studies clearly show that sexually dimorphic 
traits need to be considered in the context of population affinity. Some populations may 
be more or less robust than others, which can affect the cutoff score that separates the 
sexes in the traits that are most often analyzed. However, how ancestry affects sexually 
dimorphic traits in specific populations is still an ongoing area of research in physical 
anthropology (Garvin et al. 2014; İşcan 2005). 
  Another factor that is known to highly influence morphology is age (Williams and 
Slice 2010). Many of the sexually dimorphic traits of the skull and especially of the os 
coxa only become fully developed once the individual reaches adulthood. Therefore, the 
determination of sex in juvenile remains is considered to be highly questionable (Graw et 
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al. 1999). Once the individual reaches adulthood, the sexually dimorphic traits are 
considered fully developed and can be used to determine sex. However, as the individual 
ages, degenerative effects begin to present on the human skeleton. Osteoporosis is an 
age-related disease involving the loss of BMD that is very common in older individuals. 
According to Hudec and Camacho (2013), 4 to 6 million women and 1 to 2 million men 
in the U.S. are affected by osteoporosis. These degenerative changes have been found to 
affect the morphology of these sexually dimorphic traits in the skull and the os coxa. 
According to a study conducted by Walker (2005), the greater sciatic notch is known to 
narrow with advancing age, which can skew morphological sex assessment towards male 
in women of older age. According to Garvin et al. (2014) the nuchal crest can also 
“masculinize” with age leading to higher scores in this region. It is also common to see a 
masculinization of the skull as a whole as individuals age. This masculinization of the 
skull and pelvis is known to affect morphological sex assessment and was taken into 
account in this study (Buikstra and Ubelaker 1994).  
 Research has potentially linked differences in the morphology of sexually 
dimorphic traits to overall body size. Garvin et al. (2014) conducted a study that used 
maximum femoral lengths and femoral head diameters as proxies for body size to 
determine if there was a significant relationship between body size and the expression of 
sexually dimorphic traits of the skull. They determined that there was a statistically 
significant relationship between body size and trait score. However, the r values were 
very low and no trends could be discerned between the sexes and different population 
groups that they examined. Therefore, they determined that body size did influence 
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cranial traits but not enough to be considered necessary to include in the analysis of sex 
from sexually dimorphic traits of the skull.   
 One of the most important factors currently affecting forensic osteological 
research is secular change throughout the skeleton (Jantz and Jantz 2000). As society and 
behavioral patterns change the morphology of the skeleton can be affected (Godde 2015). 
According to Klales (2016) there has been an overall gracilization of the human skeleton 
over the past two centuries, and this must be taken into account when performing forensic 
research. The skeletal samples used for research must be reflective of the remains found 
in modern, forensic cases. If research is conducted on archaeological remains then the 
results may not correlate with modern skeletal morphology. All of these factors that are 
known to influence skeletal morphology were taken into account when conducting this 
study.    
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CHAPTER 3: MATERIALS AND METHODS 
Introduction 
 Sex assessment is a crucial component of the biological profile as it is one of the 
quickest ways to narrow the scope of a forensic investigation. Since the institution of the 
Daubert criteria in 1993, it is essential that all methods utilized by forensic 
anthropologists are as reliable and accurate as possible and have known accuracy and 
error rates. It is therefore crucial that all possible confounders of these methods are fully 
investigated and understood. According to the American Cancer Society (2017), as of 
January 2016, 15.5 million Americans were living with some history of cancer ranging 
from individuals who had been recently diagnosed and undergoing treatment to 
individuals who have been cancer free for years. Cancer is the second most common 
cause of death in the U.S., and the number of cases identified each year continues to 
grow. However, survival rates of cancer have increased since 1991, and this is mainly 
due to an increase in early detection and available treatments. The three major treatments 
for cancer include chemotherapy, radiation treatment, and surgical removal. The most 
pervasive side effect of chemotherapy and radiation treatment is CTIBL. It is the possible 
effects of CTIBL on morphological sex assessment that this study examines.  
 As a society is becoming increasingly over medicated and drug dependent, it is 
crucial to understand how these medications and treatments are affecting the methods 
utilized by forensic anthropologists. Morphological methods are some of the most heavily 
utilized techniques for determining sex. As cancer and the treatment of cancer are 
becoming more prevalent the overarching consequences of these drugs must be 
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considered. If CTIBL is affecting the robusticity of the traits examined in these methods 
than the extent of CTIBL’s effects must be thoroughly understood.  
Materials 
 In order to test the effects of CTIBL on morphological sex assessment, a sample 
of individuals was taken from the William M. Bass Donated Skeletal Collection that is 
housed at the University of Tennessee, Knoxville. The Bass Collection consists of over 
1700 individual sets of remains ranging in age from approximately birth to 100 years of 
age with a majority of the individuals having been born after 1940 (FAC 2017). The 
entire sample consisted of 356 individuals. Each individual in the study was identified by 
both UTK’s unique identification number and a study identification number. A total of 
178 of the study individuals had some history of cancer and were considered the 
experimental group. A control group was then chosen from the rest of the Bass Collection 
that was comprised of 178 individuals who paralleled the demographics of the 
experimental group as closely as possible including sex, age, and ancestry. These 
individuals were chosen from a provided list, and those who had died naturally as 
indicated by their antemortem information were given preference so as to eliminate any 
possible confounding factors in the control group.  
 The total sample consisted of 171 males and 185 females. The experimental group 
was further broken down into two subgroups of individuals that had received 
chemotherapy and/or radiation treatment versus individuals who had only received 
surgery as treatment. These subgroups consisted of 114 males and 104 females for the 
chemo and radiation group, and 58 males and 80 females for the surgery only group. The 
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entire sample consisted of European American individuals except for two African 
American, one Asian/Polynesian, and three Native American individuals. For each 
individual the sex, age-at-death, ancestry, and cause of death were available. For the 
individuals in the control group most had type of cancer and form of treatment available. 
However, there were a small number of individuals that did not have cancer type and/or 
form of treatment available. From the entire sample only 34 individuals had a history of 
cancer but did not have the type of cancer listed, 11 individuals did not have the form of 
treatment listed, and only 1 individual had a history of cancer but both the type of cancer 
and form of treatment were unknown. 
Morphological Scoring Methods 
 To begin, the individuals in the study denoted by UTK’s identification number 
were completely randomized using the excel RAND function. This was to ensure the 
study was conducted randomly and blindly to eliminate possible observer biases. For 
each individual, the entire skull and left os coxa were obtained. The left os coxa was used 
to eliminate any possible effects from right side dominance. If the left os coxa was not 
available than the right was substituted.  
 Five morphological traits were scored on the os coxa following the methods of 
Klales et al. (2012), Walker (2005), and Buikstra and Ubelaker (1994). The Klales et al. 
(2012) method focuses on three traits found in the subpubic region. These include the 
ventral arc, subpubic contour, and the ischiopubic ramus ridge. Each trait was scored on 
an ordinal scale of 1 to 5. The ventral arc was scored by orienting the os coxa with the 
anterior view facing the observer (Figure 3.1). The ventral arc is located on the anterior 
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portion of the pubic bone, perpendicular to the symphyseal face. A score of 1 indicates 
the arc was present at or above a 40° angle to the symphyseal face with a triangular area 
present beneath the arc. A score of 2 indicates the arc was present at a 25°-40° angle with 
a smaller triangular area placed inferiorly to the arc. A score of 3 indicates an arc was 
present at less than a 25° angle with a small, non-triangular area beneath the arc. A score 
of 4 was given if an arc was visible that was parallel to the symphyseal face with no 
inferiorly placed area of bone. A score of 5 was given if no arc was visible.  
 
Figure 3.1: Character Traits and Ordinal Scores for the Ventral Arc (Klales et al. 
2012: 107) 
  
 The second trait scored from the Klales et al. (2012) method is the subpubic 
contour. The subpubic contour was examined as the angle of the ischiopubic ramus ridge 
when the os coxa is oriented from the posterior view with the pubic bone held 
perpendicular to the observer (Figure 3.2). The trait was scored as a 1 when the angle was 
clearly concave just inferior to the symphyseal face and along the entire inferior ramus. A 
score of 2 was given when there was only a slight concavity that extended just inferior of 
the symphyseal face to partially down the inferior ramus. A score of 3 was given when 
there was no concavity and the inferior ramus was almost completely straight. The trait 
was scored as a 4 when the inferior pubic ramus presented with a slight convexity. A 
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score of 5 was given when the angle presented with a distinct convexity, especially along 
the inferior pubic ramus. Again, the lower scores are generally found in females, while 
the higher scores are associated with males. 
 
 
 
Figure 3.2: Character Traits and Ordinal Scores for the Subpubic Contour (Klales et al. 
2012: 107) 
 
The third trait that was scored using the Klales et al. (2012) method was the 
ischiopubic ramus ridge. This trait was observed by orienting the os coxa with the 
symphyseal face directly in front of the scorer with the ventral and dorsal edges of the 
face positioned vertically (Figure 3.3). The trait itself was found on the ascending ramus. 
A score of 1 was given when a sharp ridge was present on the ascending ramus just 
below the symphyseal face and the ramus was narrow dorso-ventrally. The trait was 
scored as a 2 when a ridge was present that was more rounded or plateaued on an 
ascending ramus that was narrow dorso-ventrally. A score of 3 was given when there was 
no ridge present but the ascending ramus was still narrow dorso-ventrally. The trait was 
scored as a 4 when there was no ridge present and the ascending ramus had a medium 
width dorso-ventrally. The trait was scored as a 5 when the ascending ramus was very 
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score of 5 was given when the angle presented with a distinct convexity, especially along 
the inferior pubic ramus. Again, the lower scores are generally found in females, while 
the higher scores are associated with males.  
 
Figure 3.2: Character Traits and Ordinal Scores for the Subpubic Contour (Klales et 
al. 2012: 107) 
  
 The third trait that was scored using the Klales et al. (2012) method was the 
ischiopubic ramus idge. T is trait was observed by orienting the os coxa with the 
symphyseal fa e directly in front of the scorer with the ventral and dorsal edges of the 
face position d vertically (Figure 3.3). The trait itself was found on the ascending ramus. 
A score of 1 was given when a sharp ridge was p esent on the asce ing ramus just 
below the symphyseal face and the ramus was narrow dorso-ventrally. The trait wa  
scored as a 2 when a ridge was present that was more rounded or plate ued on an 
ascending ramus that was narro  dorso-ventrally. A sc re of 3 was given when there was 
no ridge present but the ascending ramus was still narrow dorso-ventrally. The trait was 
scored as a 4 when there was no ridge present and the ascending ramus had a medium 
width dorso-ventrally. The trait was scored as a 5 when the ascending ramus was very 
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wide dorso-ventrally and no ridge was present. The lower scores indicated a female while 
the higher scores indicated a male. 
 
Figure 3.3: Character Traits and Ordinal Scores for the Ischiopubic Ramus Ridge 
(Klales et al. 2012: 107) 
 
The fourth trait scored on the os coxa was the greater sciatic notch (GSN) 
following the method laid out in Walker (2005) and in Buikstra and Ubelaker (1994). In 
order to properly score the GSN, the os coxa was oriented so that the auricular surface 
was visible and both the GSN and auricular surface were perpendicular to the observer 
(Figure 3.4). The GSN was then  
scored on an ordinal scale of 1 to 5 based on the width of the angle. The os coxa was 
oriented properly and then held approximately six inches above the provided diagrams in 
Walker (2005). The score that most closely aligned with the GSN was then recorded. The 
scores of 1 and 2 are the widest greater sciatic notches and are associated with females. 
The scores of 4 and 5 are the narrowest greater sciatic notches and are more common in 
males. A score of 3 was considered indeterminate.  
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Figure 3.4: Proper Orientation, Character Traits, and Ordinal Scores for the 
Greater Sciatic Notch (Walker 2005:386) 
 
The fifth trait scored on the os coxa was the preauricular sulcus. This 
morphological feature is a small depression located just inferior to the auricular surface 
of the os coxa (Figure 3.6). The presence of a preauricular sulcus indicates female as it is 
typically only found on females. However, the preauricular sulcus was scored on an 
ordinal scale from 0 to 4 as outlined in the Buikstra and Ubelaker (1994) method. A score 
of 0 indicates the complete absence of a preauricular sulcus while scores of 1 through 4 
indicate different forms of the preauricular sulcus. This scoring system is different from 
the other ordinal scoring systems used as it is not a scale from male to female. Due to this 
difference in the meaning of the ordinal scores, the scores for the preauricular sulcus 
were excluded from the statistical analysis. 
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Figure 3.4: Proper Orientation, Character Traits, and Ordinal Scores for the Greater 
Sciatic Notch (Walker 2005:386) 
 
The fifth trait scored on the os coxa was the preauricular sulcus. This 
morphological feature is a small depression located just inferior to the auricular surface 
of the os coxa (Figure 3.6). The presence of a preauricular sulcus indicates female as it is 
typically only found on females. However, the preauricular sulcus was scored on an 
r i l s ale from 0 to 4 as outlined in the Buikstra and Ubelak r (1994) method. A score 
f i ates the complet  absence of a preauricular sulcus while scores f 1 throug  4 
indicate different forms of the preauricular sulcus. This scoring system is different from 
the other ordinal scoring systems used as it is not a scale from male to female. Due to this 
difference in the meaning of the ordinal scores, the scores for the preauricular sulcus 
were excluded from the statistical analysis.  
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Figure 3.5 Character Traits and Ordinal Scores for the Preauricular Sulcus 
(Buikstra and Ubelaker 1994:19) 
 
The second skeletal region scored was the skull and scoring focused on five traits 
utilizing the methods laid out in Walker (2008). Four of the traits are found on the 
cranium and the fifth is found on the mandible (Figure 3.6). These five traits consist of 
the nuchal crest, mastoid process, supraorbital margin, glabella and mental eminence. 
Each trait was scored on an ordinal scale of 1 to 5 with the lower scores being associated 
with female and the higher scores being associated with males. When a trait presented 
bilaterally, the left side was utilized for consistency. If the left side was unavailable than 
the right was used. 
The nuchal crest is a muscle attachment point at the midline on the occipital. To 
score this trait the cranium was held from a lateral view with the left side showing 
(Figure 3.6). The extent of the protrusion of the crest was then scored based on its 
approximation to the scores laid out in Walker (2008). The mastoid process is a large, 
rounded muscle attachment point that protrudes from the cranium just inferior to the 
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Figure 3.5 Character Traits and Ordinal Scores for the Preauricular Sulcus (Buikstra 
and Ubelaker 1994:19) 
 
The second skeletal region scored was the skull and scoring focused on five traits 
utilizing the meth ds laid out in Walker (2008). Four of the traits are f und on the 
cranium and the fifth is found on the mandible (Figure 3.6). These five traits consist of 
the nuchal crest, mastoid process, supraorbital margin, glabella and mental eminence. 
Each trait was scored on an ordinal scale of 1 to 5 with the lower scores being associated 
with female and the higher scores being associated with males. When a trait presented 
bilaterally, the left side was utilized for consistency. If the left side was unavailable than 
the right was used.  
 The nuchal crest is a muscle attachment point at the midline on the occipital. To 
score this trait the cranium was held from a lateral view with the left side showing 
(Figure 3.6). The extent of the protrusion of the cr st was then scored based on its 
approximation to the scores laid out in Walker (2008). The mastoid process is a large, 
rounded muscle attachment point that protrudes from the cranium just inferior to the 
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external acoustic meatus (Figure 3.6). The left mastoid process was viewed by holding 
the cranium from the same left lateral view as the nuchal crest. The mastoid process was 
scored based on its overall size and volume in relation to the external acoustic meatus. 
The larger the mastoid process, the higher the score as depicted in Walker (2008). The 
supraorbital margin is the superior margin of the orbital socket just lateral to the 
supraorbital notch/foramen (Figure 3.6). The left supraorbital margin was scored based 
on the sharpness of the margin. The examiner ascertains the angle of the margin by gently 
pressing the pad of the thumb along the margin. The lower scores indicated a sharper 
margin, and therefore, a female. The higher scores signified a blunter more rounded 
margin, and therefore, more likely a male.  
 The glabella is a rounded protrusion centered at the midline of the frontal bone, 
just superior to the nasal bones. This area was viewed by orienting the cranium from a 
left, lateral view (Figure 3.6). The glabella was scored based on its overall size and extent 
of protrusion as described in Walker (2008). The lower scores described a smaller 
glabella associated with females, and the higher scores signified a larger glabella 
associated with males. The final trait examined was the mental eminence found at the 
midline and most anterior point on the mandible (Figure 3.6). The mental eminence was 
based on its overall size as well as shape. A lower score indicates a mental eminence that 
is small, extends superiorly on the mandible, and lacks significant anterior protrusion. 
The higher scores described a very large mental eminence that potentially extended as far 
superiorly as the alveolar process and protruded significantly in an anterior direction. The 
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overall size of the mental eminence was determined by the examiner using both thumbs 
to palpate the lateral borders of the mental eminence.  
 
Figure 3.5: Character Traits and Ordinal Scores for Traits of the Skull (Walker 
2008:41). 
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All of the individuals examined were scored randomly and blindly, and all of the 
scores taken for each individual were entered into an Excel spreadsheet. Once all of the 
individuals were scored from both the drugs subgroup and the surgery subgroup, 10% 
(n=36) of the entire sample was rescored to test for intraobserver error. These individuals 
were chosen at random from the entire sample using the Excel RAND function. The UTK 
IDs were copied into a separate column and the RAND function was used to randomize 
the sample. Once this was done, the first 36 individuals were chosen for the intraobserver 
error test. All ten traits were rescored on these individuals using the same methods 
outlined above.  
 After all of the individuals and the individuals chosen for intraobserver 
error had been scored and/or rescored, photographs were taken of each possible score for 
each trait using selected individuals that were highly representative of those scores. Once 
photographs were completed, each individual was re-associated with their general 
demographic information including sex, age, ancestry and cause of death. The type of 
cancer and exact form of treatment for the individuals in the experimental group were 
then noted. The individuals were then assigned to two age cohorts with individuals 
grouped together as ≤ 59 years at death or ≥ 60 years at death in order to account for 
known age-related changes in of the traits including the GSN and nuchal crest. These age 
cohorts were then also separated by sex. When the sample had been entirely separated 
into cohorts by sex, age group, and subgroup (drugs vs. chemo), the statistical analyses 
were conducted. In order to determine sex using the ordinal scores produced by the 
methodologies utilized, logistic regression functions must be used. For the purposes of 
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this study those logistic regression functions were ignored, as a final determination of sex 
for each individual was not relevant to this study.  
Statistical Analysis Methods 
 Two statistical analyses were conducted in this study to assess the presence and 
nature of the relationship between the trait scores and the individual’s cancer treatment 
status. Only nine of the 10 traits were utilized in the statistical analysis. The pre-auricular 
sulcus was not included in the analyses because its scoring method is fundamentally 
different from the other 9 traits. Therefore, any results from the pre-auricular sulcus 
would not have the same meaning as the other traits when conducting the same statistical 
analyses. Also, any individuals that had any traits that were unscorable were also 
removed resulting in a total sample size of 330 individuals that were used in the analyses. 
The statistical analyses were performed using the IBM Statistical Package for Social 
Sciences (SPSS). The first statistical test performed was the Chi-Square test, which was 
used to determine if differences exist in trait scores between the control group and the 
experimental group. This test was run three times to compare the scores under three 
different conditions. The first test compared morphological trait scores between the 
sexes, the second test compared the trait scores between the control and experimental 
groups, and the third test compared the morphological trait scores between the control 
and experimental groups with sex as a variable. This three-test process was conducted 
with all of the traits together. The individuals were separated out into two subgroups that 
included individuals who were known to have undergone radiation and/or chemotherapy 
and individuals who had only undergone surgery as a form of treatment. This was due to 
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the fact that CTIBL is not a side effect linked as heavily to surgery as a treatment for 
cancer. The Chi-Square test produces a p-value that indicates whether there is a 
significant difference between the compared variables. A p-value of 0.05 or lower is 
considered significant.  
 The Chi-Square test is effective at determining if there is a difference between 
groups, but it does not indicate what is different or if there is a relationship between 
specific variables. In order to determine relationships between variables, one-way 
Analysis of Variance (ANOVA) test was conducted. This test determined if there was a 
significant relationship between the trait scores and the cancer treatment status of the 
individual. The ANOVA was also used to determine the level of significance between the 
cancer treatment status of the individual and each separate morphological trait, as it was 
possible that only certain traits may be affected by CTIBL. The score of the 
morphological trait was considered the dependent variable while sex and cancer 
treatment status were run as fixed factors. The ANOVA test produced p-values to assess 
the significance of the relationship. Again, only values of 0.05 or lower were considered 
significant.  
 Age also needed to be taken into account in this study because several of the 
sexually dimorphic traits utilized, including the GSN and the nuchal crest, are known to 
be affected by age. To account for these possible variations, a one-way Analysis of 
Covariance (ANCOVA) was also conducted. Running an ANCOVA indicated whether 
age was a significant factor in determining the scores of the morphological traits. The 
process for running an ANCOVA analysis was similar to an ANOVA test. Age was 
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simply added in as data and considered a covariate during the analysis. Age was divided 
into two groups with the younger group including individuals aged 59 and younger and 
the older including individuals who were 60 and older. The ages were segregated this 
way because dividing them into decades would have produced sample sizes that were too 
small. Additionally, the sample included a large number of older individuals, so age was 
divided between 59 and 60 to keep the sample sizes more even. Cancer treatment status 
and sex were still considered as data in the ANCOVA analysis. The score of the 
morphological trait was again run as the dependent variable while cancer treatment status 
and sex were run as fixed factors. The ANCOVA produced p-values indicating the 
significance of the data. Only p-values of 0.05 or less were considered significant.  
 Intraobserver agreement was also evaluated using SPSS. All of the methods 
utilized to score the morphological traits are subjective methods. The scores chosen were 
based on the observer’s decision as to which score most closely matched what was being 
observed on the skeletal element. Therefore, there is room for significant variation in 
scoring. Thirty-six donors were then rescored using the same methodologies utilized for 
the original sample scoring. All nine traits were rescored as available.  
 Once the 36 donors had been rescored, the scores from the original trial were 
compared to the intraobserver scores in SPSS using a Cohen’s Kappa analysis. This 
analysis produced both p-values indicating the statistical significance of the intraobserver 
scores compared to the original scores and kappa values for each trait indicating the 
strength of agreement between the two trials. Kappa values can range from -1 to +1 with 
higher kappa values indicating stronger agreement between the two trials. Accordingly, 
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<0.00 was considered poor, 0.00-0.20 was considered slight, 0.21-0.40 was considered 
fair, 0.41-0.60 was considered moderate, 0.61-0.80 was considered substantial and 0.81-
1.00 was considered almost perfect agreement following Landis and Koch (1977).  
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CHAPTER 4: RESULTS 
Introduction 
 Overall, no significant relationship was found between the cancer treatment status 
of the individual and the scores of the visually assessed morphological traits. Both the 
Chi-square analyses and the ANOVA analyses revealed no significant correlation 
between the cancer treatment status of the individual and the expression of the sexually 
dimorphic traits. This was true for both the os coxa and the skull. The ANCOVA 
analyses revealed that age was only a significant factor for the mastoid process in the 
drug group. No significant relationship was found at the individual trait level, with the 
exception of the ventral arc in the surgery group when conducting an ANOVA analysis. 
Cancer treatment status was only significant in the ventral arc of the surgery group when 
the sexes were pooled.  
Chi-Square Analyses 
 The Chi-square analysis resulted in no significant relationship between cancer 
treatment status of the individual and the scores of the morphological traits. The analyses 
resulted in p-values greater than 0.05 for all traits scores when compared between the 
experimental and control groups. These results were the same whether sex was included 
as a variable or not. A significant relationship was found between the morphological 
traits scores and the sex of the individual. However, this was highly expected as previous 
research has demonstrated that these traits are highly correlated with sex. The Chi-square 
analysis also resulted in p-values greater than 0.05 when the individuals with drug-based 
treatments were analyzed separately from the individuals with surgery-based treatment.  
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Total Sample 
 The sample was tested in its entirety to determine if a significant relationship 
exists between cancer treatment status and the scores of the visually assessed traits. Sex 
was determined to be statistically significant at the 0.00 level. Cancer treatment status 
was not found to be significant even when sex was not included as a variable. A Chi-
square analysis compared trait scores and cancer treatment status without sex as a layer. 
All of the p-values generated by this analysis are summarized in table 4.1. and none are 
significant at the 0.05 level.  
 The same Chi-square analyses were conducted again for the total sample but with 
sex included as a variable. No significant relationship was observed between cancer 
treatment status and the scores of the sexually dimorphic traits except for the glabella in 
females. This was determined to be statistically significant at the 0.05 level. A Chi-
Square analysis comparing the cancer treatment status of individuals to the scores of the 
glabella in all females produced a p-value of 0.047, which is considered to be significant. 
All p-values generated in this analysis are summarized in table 4.1.  
Drug Subgroup 
 A Chi-square analysis was conducted to compare the scores of the morphological 
traits to the sex of the individual for the subgroup that had received radiation and/or 
chemotherapy as treatment. As expected, it was found that the trait scores were highly 
correlated with sex. The p-value for each trait was significant at the 0.00 level. This test 
was conducted as a benchmark to ensure the data was consistent with previous research, 
which indicates that the trait scores are highly correlated with sex.   
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 The Chi-square analysis was then run to compare the scores of the morphological 
traits and the cancer treatment status of the individual excluding sex as a variable. The 
traits were analyzed in the order that they were scored. All p-values generated in this 
analysis indicated no significant relationship between the score of the sexually dimorphic 
trait and the cancer treatment status of the individual when sex was not taken into 
account. All p-values for this analysis are summarized in Table 4.1.  
 A Chi-square analysis was also conducted to compare the scores of the visually 
assessed traits and the cancer treatment status of the individual with sex as a layer in the 
analysis. This was to determine if there was a difference between the sexes in the 
significance of the cancer treatment status of the individuals in the drug subgroup. The p-
values indicated that there was no significant correlation at the 0.05 level between the 
cancer treatment status of the individuals and the scores for the sexually dimorphic traits 
in the drug subgroup even when sex was considered as a variable. All p-values for this 
analysis are summarized in Table 4.1.  
Surgery Subgroup 
 The same Chi-square analyses were conducted for the subgroup of individuals 
who had only surgery documented as a form of treatment. For this group, the only 
significant relationship was found between the score of the traits and the sex of the 
individual. All of the p-values generated in the analysis comparing sex and the scores of 
the traits were found to be at the 0.00 level. Again, this was expected as sex is highly 
correlated with the score of the morphological traits analyzed, as shown via the extremely 
low p-values generated.  
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 Chi-square analyses were conducted to compare the scores of the morphological 
traits and the cancer treatment status of the individuals in the surgery subgroup with the 
pooled sexes. All of the p-values indicated no significant relationship between cancer 
treatment status and trait score at the 0.05 level when the sexes were pooled. All of the p-
values generated for this analysis are summarized in Table 4.1.  
 The same Chi-square analyses were conducted again with sex as a variable to 
determine if cancer treatment status in the surgery subgroup was significant when the 
sexes were divided. Based on the results of the analysis, no significant relationship exists 
at the 0.05 level between the cancer treatment status of the individual and the scores of 
the visually assessed traits when the sexes were separated. All p-values for this analysis 
are summarized in Table 4.1.  
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Table 4.1. Results of Chi-Square Analyses for sexually dimorphic traits and study 
subgroups (p-values). 
*Statistically significant at 0.05 level.
Sexually 
dimorphic 
traits 
Pooled-
No sex 
(n=330) 
Pooled-
Female 
(n=169) 
Pooled-
Male 
(n=161) 
Drug-
No sex 
(n=201) 
Drug-
Female 
(n=95) 
Drug-
male 
(n=106) 
Surgery-
No sex 
(n=129) 
Surgery-
Female 
(n=74) 
Surgery-
Male 
(n=55) 
Ventral Arc 0.997 0.832 0.963 0.911 0.338 0.849 0.742 0.329 0.386 
Subpubic 
Contour 0.800 0.273 0.983 0.791 0.645 0.856 0.532 0.104 0.399 
Ischiopubic 
Ramus 
Ridge 
0.965 0.810 0.367 0.466 0.907 0.184 0.654 0.722 0.187 
Greater 
Sciatic 
Notch 
0.435 0.897 0.422 0.428 0.429 0.617 0.215 0.191 0.464 
Nuchal 
Crest 0.651 0.722 0.124 0.794 0.539 0.516 0.392 0.745 0.068 
Mastoid 
Process 0.882 0.857 0.888 0.964 0.819 0.997 0.726 0.896 0.375 
Supraorbital 
Margin 0.407 0.395   0.629 0.795 0.183 0.930 0.452 0.581 0.480 
Glabella 0.596 0.047*  0.607 0.794 0.361 0.485 0.748 0.173 0.655 
Mental 
Eminence 0.227 0.106 0.964 0.480 0.424 0.721 0.110 0.146 0.647 
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ANOVA Analyses 
 To confirm the results of the Chi-square analyses, ANOVA analyses were also 
conducted on each separate trait. The analysis was run for the total, pooled sample and 
for the subgroups of drug-based treatments and surgery treatments. All of the traits 
produced p-values greater than 0.05 when compared via the cancer treatment status, 
except for the ventral arc in the surgery subgroup when sex was not considered as a 
factor. This was another indication that no significant relationship exists between the 
cancer treatment status of the individual and the scores of the morphological traits.   
Total Sample 
 An ANOVA analysis was conducted on the pooled sample in order to understand 
if there was any direct correlation between cancer treatment status and the scores of the 
morphological traits. No statistically significant relationship was observed between 
cancer treatment status and the scores of the visually assessed traits both with and without 
the consideration of sex. All p-values were above the 0.05 level. All p-values for this 
analysis are summarized in Table 4.2.  
Drug Subgroup 
 An ANOVA analysis was conducted on the drug-based treatment subgroup with 
the scores of the morphological trait as the dependent variable while sex and the cancer 
treatment status of the individual were run as fixed factors. P-values indicate the 
significance of sex alone, the cancer treatment status alone, and the sex and cancer 
treatment status together. No significant relationship was found between cancer treatment 
status and the scores of the traits whether sex was considered or not. All of the traits 
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produced p-values at the 0.00 level for the sex of the individual indicating a significant 
relationship. This was highly expected as a significant relationship between sex and the 
scores of these visually assessed traits is well documented. All p-values for this analysis 
are summarized in Table 4.2.  
Surgery Subgroup 
 The same ANOVA analysis was conducted for the surgery-based treatment 
subgroup. Again, the only significant relationship was found between the trait scores and 
sex with all traits producing p-values at the 0.00 level. However, the ventral arc did 
indicate a level of statistical significance at the 0.05 level when cancer treatment status 
was considered separately from sex. The ventral arc produced a p-value of 0.010 for 
cancer treatment status alone indicating a significant relationship between the scores of 
the ventral arc and the cancer treatment status of the individual when sex is not 
considered as a variable. All p-values from this analysis are summarized in table 4.2.  
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Table 4.2: Results of ANOVA Analyses of sexually dimorphic traits and study 
subgroups (p-values). 
*Statistically Significant at 0.05 level. 
 
ANCOVA Analyses 
 It has been well documented that age can affect the scoring of some of the 
sexually dimorphic traits used to assess sex. The nuchal crest and the greater sciatic notch 
are especially susceptible to age-related changes. In order to account for this variable in 
the data an ANCOVA was run for each trait both with the entire sample and separated by 
treatment subgroup with the trait scores run as the dependent variable and cancer 
treatment status and sex run as fixed factors. Age was determined to be statistically 
significant for several of the traits when the data was pooled between the two subgroups. 
Age was determined to be a significant factor in the scoring of the subpubic contour, 
Sexually 
dimorphic traits 
Pooled-
Cancer 
(n=330) 
Pooled-Sex 
and Cancer 
(n=330) 
Drug-
Cancer 
(n=201) 
Drug-Sex 
and Cancer 
(n=201) 
Surgery-
Cancer 
(n=129) 
Surgery-Sex 
and Cancer 
(n=129) 
Ventral Arc 0.972 0.642 0.073 0.930 0.010* 0.882 
Subpubic 
Contour 
0.707 0.282 0.422 0.359 0.100 0.785 
Ischiopubic 
Ramus Ridge 
0.567 0.851 0.236 0.595 0.541 0.599 
Greater Sciatic 
Notch 
0.898 0.528 0.681 0.771 0.594 0.203 
Nuchal Crest 0.562 0.297 0.513 0.491 0.062 0.271 
Mastoid Process 0.556 0.946 0.893 0.967 0.423 0.945 
Supraorbital 
Margin 
0.751 0.755 0.965 0.928 0.680 0.741 
Glabella 0.099 0.222 0.251 0.639 0.292 0.208 
Mental 
Eminence 
0.503 0.876 0.643 0.963 0.630 0.864 
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ischiopubic ramus ridge, nuchal crest, and mastoid process. For all of the other traits for 
the combined data, age was determined to not be statistically significant. All p-values for 
this analysis are summarized in Table 4.3.  
Drug Subgroup 
 An ANCOVA analysis was also conducted on the two different subgroups of the 
data to determine the significance of age for each trait in each subgroup. For the drug-
based treatment subgroup, age was only found to be significant for the ischiopubic ramus 
ridge and the mastoid process. The p-values of these traits were 0.005 and 0.016 
respectively. Age was not a significant factor for any of the other traits for this subgroup. 
All p-values generated in this analysis are summarized in Table 4.3.  
Surgery Subgroup 
 The same ANCOVA analysis was run to determine the significance of age in the 
surgery treatment subgroup. Age was not a significant variable for any of the traits in this 
subgroup at the 0.05 level. The p-values generated by this analysis are summarized in 
Table 4.3.  
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Table 4.3. Results of ANCOVA Analyses of sexually dimorphic traits and study 
subgroups (p-values). 
*Statistically Significant at the 0.05 level. 
 
Intraobserver Agreement Analyses 
 All of the methods utilized in this study are highly subjective and based on the 
interpretation of the observer. In order to test for any possible variation in scoring 
generated via the observer’s choices, 10% of the sample was randomly selected rescored. 
These rescored individuals were then compared to the original scores via Cohen’s Kappa 
analyses. This analysis tests intraobserver agreement and can range from a score of -1 to 
+1. The significance of the agreement is also derived from the analysis and presented in 
p-values. Again, any value under 0.05 was considered significant. The results of this 
analysis are summarized in Table 4.4.  
 
Sexually dimorphic traits Pooled (n=330) Drug Subgroup (n=201) Surgery Subgroup (n=129) 
Ventral Arc 0.107 0.387 0.172 
Subpubic Contour 0.018* 0.148 0.086 
Ischiopubic Ramus Ridge 0.001* 0.005* 0.051 
Greater Sciatic Notch 0.095 0.078 0.663 
Nuchal Crest 0.043* 0.080 0.330 
Mastoid Process 0.004* 0.016* 0.188 
Supraorbital Margin 0.387 0.991 0.162 
Glabella 0.898 0.676 0.413 
Mental Eminence 0.886 0.938 0.863 
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Table 4.4: Intraobserver Agreement Results 
Sexually Dimorphic Traits Cohen’s Kappa (k) Level of Agreement (Landis and Koch 1977) 
Ventral Arc 0.607 Moderate 
Subpubic Contour 0.607 Moderate 
Ischiopubic Ramus Ridge 0.587 Moderate 
Greater Sciatic Notch 0.715 Substantial 
Nuchal Crest 0.699 Substantial  
Mastoid Process 0.636  Substantial 
Supraorbital Margin 0.406 Fair 
Glabella 0.720 Substantial 
Mental Eminence 0.432 Moderate 
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CHAPTER 5: DISCUSSION 
Introduction 
 The vast majority of the p-values produced in the Chi-square and ANOVA 
analyses indicated no significant relationships between the trait scores and the cancer 
treatment status of the individuals. Based on the results of this study, the hypothesis that 
cancer treatment results in more gracile sexually dimorphic traits is rejected. CTIBL does 
not appear to affect the robusticity of the nonmetric sexually dimorphic traits commonly 
utilized in morphological sex assessment, and therefore, sex assessment is not skewed 
towards gracile by the presence of CTIBL. There were two traits that indicated a possible 
relationship between the trait score and the cancer treatment status of the individual. 
These traits were the ventral arc of individuals who underwent surgery as treatment and 
the glabella of females in the total sample. A Chi-square analysis of the glabella produced 
a p-value of 0.047 (slightly significant) for females in the total sample when compared by 
cancer treatment status (see Table 4.1). An ANOVA analysis of the ventral arc of 
individuals who had undergone surgery as treatment produced a p-value of 0.010 for 
cancer treatment status alone when sex was not considered. These results are below the 
p=0.05 level, and therefore, indicate a statistically significant relationship between the 
scores of the ventral arc and glabella and the cancer treatment status of the individual.   
Chi-Square Analyses 
 All of the traits revealed a significant relationship between the scores and sex at 
the 0.05 level. This analysis was conducted to establish a baseline for the data and to 
ensure that the data fit with previously published standards on the sexual dimorphism of 
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these traits. It has been well established that the morphological traits examined are 
sexually dimorphic, and therefore, can be used to determine the sex of the individual 
(Buikstra and Ubelaker 1994; Klales et al. 2012; Walker 2005; Walker 2008) 
 When analyses were conducted that compared the trait scores to the cancer 
treatment status of the individual with the sexes pooled, none of the traits resulted in a 
statistically significant relationship (see Table 4.1). This makes sense because if there 
were a significant relationship, pooling the sexes would cause that signal to be lost in the 
noise since the scoring is designed to distinguish the sexes. When sex was considered as a 
variable, only one trait resulted in a significant relationship between the trait scores and 
cancer treatment status. This was the glabella of females in the combined treatment status 
sample, which produced a p-value of 0.047 (Table 4.1). This indicates that the glabella of 
females who have undergone some form of cancer treatment may be affected by the 
cancer treatment. However, the significance is slight.  
 The glabella is not a muscle attachment site on the skull, so it is not as susceptible 
to degenerative changes as many of the other morphological traits examined in this study 
(Buikstra and Ubelaker 1994). According to the ANCOVA analyses conducted, age was 
also not a contributing factor to the scoring of this trait. Therefore, it is absolutely 
possible that CTIBL does affect the glabella by increasing the osteoclastic activity in this 
region, resulting in a net loss of cortical bone (D’Oronzo et al. 2015). However, if CTIBL 
is resulting in a loss of cortical bone for this trait in females, it would actually cause the 
trait to be skewed more towards hyperfeminine. Therefore, this may make an overall sex 
assessment for females easier using the glabella. 
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ANOVA Analyses 
 All of the results for this analysis lacked statistical significance except for the 
ventral arc of individuals in the surgery subgroup when sex was not considered as a 
variable. This trait generated a p-value of 0.010, which is considered highly statistically 
significant (Table 4.2). However, when sex was considered for this trait in this group, no 
statistical significance was found. The ventral arc is a site of muscle attachment and due 
to the muscular differences between males and females in this region, the resulting bony 
site of attachment is highly sexually dimorphic (Anderson 1990; Klales et al. 2012). As a 
site of muscle attachment this trait is susceptible to age related changes over time. 
However, the ANCOVA analysis resulted in no statistical relationship between the 
ventral arc and the age of the individual (see Table 4.3). Therefore, the scores of the 
morphological traits for the all individuals in the surgery subgroup were dependent on the 
cancer treatment status. This is most likely because the symphyseal region where the 
ventral arc is located is a thinner area of bone, and is therefore, more likely to be 
susceptible to CTIBL. Cancer Treatment-Induced Bone Loss can affect cortical bone but 
more heavily affects the inner trabecular bone (Pietschmann et al. 2003). Both the 
cortical and trabecular bone of the symphyseal region are thinner as compared to many of 
the other morphological traits examined in this study, so any net loss of bone would be 
more drastic in this region. The net loss of bone that is a direct result of CTIBL was 
therefore more substantial around the ventral arc resulting in a statistically significant 
difference between the individuals who had undergone cancer treatment and those who 
had not. 
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 It is also important to note that three other results were very close to being 
statistically significant. These were the glabella in the pooled group when sex was not 
considered, the ventral arc in the drug group when sex was not considered, and the nuchal 
crest in the surgery group when sex was not considered. These analyses resulted in p-
values of 0.099, 0.073, and 0.062, respectively (see Table 4.2). This is important, as the 
glabella and the ventral are the same traits that resulted in a statistically significant 
relationship between the scores of the morphological traits and cancer treatment status. 
The glabella was also significant in the pooled group for both analyses. This indicates 
even more strongly that the glabella may be affected by CTIBL due to the fact that it is 
not an area of muscle attachment and was not affected by age in this study. The fact that 
the ventral arc was nearly significant in the drug treatment subgroup also adds support to 
the hypothesis that the ventral arc is affected by CTIBL to the point of affecting the trait 
scoring. As the ventral arc is an area of muscle attachment, it is more susceptible to 
changes over time (Buikstra and Ubelaker 1994). These changes are highly associated 
with age, but age was not a statistically significant variable for the ventral arc. Therefore, 
any differences between the cancer treatment groups and the control group can be 
attributed to a net loss of bone in the cancer treatment groups resulting from CTIBL 
(D’Oronzo et al. 2015).  
ANCOVA Analyses 
 Age was an important factor to consider in this study, as it is known to affect the 
morphology of the sexually dimorphic traits examined in this study. When age was 
included as a variable in the ANCOVA analyses the lack of statistical significance 
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between the scores of the traits and the cancer status of the individuals remained the 
same. Age as a variable was determined to be significant in four out of the nine traits in 
the pooled group, and two of those traits were also statistically significant in the drug 
group. The significant traits in the pooled group included the subpubic contour, 
ischiopubic ramus ridge, nuchal crest, and mastoid process. The p-values for these traits 
were 0.018, 0.001, 0.043, and 0.004, respectively as presented in Table 4.3. The 
ischiopubic ramus ridge and mastoid process were also statistically significant in the drug 
group. The p-values for these traits were 0.005 and 0.016, respectively (see Table 4.3). 
None of the other traits in any of the groups resulted in a significant relationship between 
the score of the traits and the age of the individual.  
 Age was statistically significant for the mastoid process and the nuchal crest. This 
is due to the fact that the skull is highly susceptible to age-related changes (Buikstra and 
Ubelaker 1994; Garvin et al. 2014). Both the mastoid process and the nuchal crest are 
areas of significant muscle attachment. Throughout an individual’s life these muscles will 
actually influence the shape of the bone as bone is a highly adaptive material that will 
respond to biomechanical stresses by increasing bone metabolism and production (Currey 
2002). Due to the adaptive nature of bone, the nuchal crest is known to “masculinize” 
with age resulting in larger nuchal crests, especially in females (Garvin et al. 2014). This 
is most likely why cancer treatment status was not a significant determiner of the scoring 
for either of these traits. Any significant differences in scoring for these two traits can be 
attributed to normal age-related changes as biomechanical stresses are more severe in 
these regions.   
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 The ischiopubic ramus ridge and the subpubic contour were also affected by age 
to a statistically significant amount. These two traits are not sites of muscle attachments 
and are created through developmental changes associated with the pelvic region 
(Anderson 1990; Coleman 1969; Klales et al. 2012). Therefore, these two traits due not 
experience the same direct muscular stresses that many of the other traits do. However, 
the pelvic region is vital in bipedal motion, and therefore, experiences large 
biomechanical stresses throughout on a daily basis. The os coxae are also highly 
influenced by sex due to the female ability to birth children. These different 
biomechanical and life stresses can highly influence these regions, and therefore, the 
traits themselves. This is why age can significantly affect these two traits even if they are 
not sites of direct muscle attachment.   
 There were several traits where age was very close to being statistically 
significant that should be noted. The age for the greater sciatic notch was nearly 
statistically significant in the pooled group and the drug group. The p-values for these 
analyses were 0.095 and 0.078, respectively (see Table 4.3). This is expected, as 
according to Walker (2005), the greater sciatic notch is known to “masculinize” with age 
due to the severe biomechanical stresses experienced by the os coxae. Age for the 
subpubic contour was nearly significant in the surgery group with a p-value of 0.086 (see 
Table 4.3). Age for the ischiopubic ramus ridge, which was statistically significant in the 
pooled and drug groups, was also nearly significant in the surgery group. The p-value for 
this analysis was 0.051 (see Table 4.3). Age for the nuchal crest, which was statistically 
significant in the pooled group, was nearly statistically significant in the drug group with 
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a p-value of 0.080 (see Table 4.3). Due to the adaptive nature of bone and the severe 
biomechanical stresses experienced through life, age was a statistically significant factor 
in the morphology of several of the traits examined in this study.   
Intraobserver Agreement Analyses 
 The use of visually assessed sexually dimorphic morphological traits to assess sex 
is commonplace in forensic anthropology. However, these methods are subjective and 
based on the observer’s interpretation. Therefore, it is important to understand 
statistically how accurate and consistent the observer is when scoring the traits. In order 
to test this, a Cohen’s Kappa analysis was conducted that compared the original trait 
scores to the trait scores of 36 individuals that were rescored. The kappa values can range 
from -1 to +1 with higher values indicating higher intraobserver agreement. This analysis 
was conducted for each trait, and it was determined that intraobserver agreement was 
fairly high with four of the traits producing moderate intraobserver agreement, four of the 
traits generating substantial intraobserver agreement, and one trait yielding only fair 
intraobserver agreement. Therefore, overall intraobserver agreement ranged between 
moderate and substantial intraobserver agreement. The only trait that was below 
moderate agreement was the supraorbital margin. According to Pinto et al. (2016), high 
intra- and inter-observer error rates are common for this trait. Therefore, lower 
intraobserver agreement for this trait is not outside the norm for forensic anthropology. 
The four traits that produced substantial intra-observer agreement were the greater sciatic 
notch, mastoid process, nuchal crest, and glabella (see Table 4.4). These four traits are all 
generally very large and easily scored based on their size resulting in higher intra-
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observer agreement. The four traits that resulted in moderate intra-observer agreement 
were the ventral arc, subpubic contour, ischiopubic ramus ridge, and the mental eminence 
(see Table 4.4). These are all traits that are scored based on their shape as opposed to 
their size. This makes the scoring of these traits slightly more difficult as there is more 
room for interpretation when determining the shape of a trait versus its size. These results 
indicate that the observer was relatively consistent with her scoring, and therefore, the 
results of the analyses comparing trait score to cancer treatment status can be considered 
reliable. 
Study Implications/Limitations 
 Overall, no strong correlation was established between cancer treatment status 
and the scores of the visually assessed morphological traits. However, two of the analyses 
did indicate a possible correlation between cancer treatment status and the scores of the 
glabella and ventral arc. Therefore, there are implications and limitations to this study 
that must be addressed.  
Implications 
 Based on the statistically significant results indicating that cancer treatment status 
can affect the scoring of the ventral arc and the glabella, it may be advisable to utilize 
these traits with caution when determining sex morphologically. However, the glabella 
may only need to be used with caution in males as in females CTIBL would be skewing 
the scoring of the glabella towards hyperfeminine resulting in a more certain overall sex 
assessment of female. Unfortunately, it is nearly impossible to diagnosis an individual 
with cancer from their skeleton unless the cancer has metastasized to the bone. Unless 
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metastatic degeneration has occurred, no sure signs of cancer are visible on bone. 
Osteoporosis may indicate that the individual has undergone cancer treatment and is 
experiencing CTIBL. However, osteoporosis is also a natural degenerative disease and is 
not only attributable to CTIBL. Therefore, it is unlikely that the forensic anthropologist 
will know to eliminate these traits from their determination of sex. It may be possible to 
recognize cancer treatment via the skeleton if the BMD is measured and determined to be 
extremely low throughout. However, measuring the BMD of a skeleton is not common 
practice in a forensic setting. That being said, CTIBL can lead to an increased risk of 
metastasized cancer resulting in more destruction of bone (D’Oronzo et al. 2015; Wright 
and Guise 2014). Therefore, it is possible that individuals who have undergone cancer 
treatment and must be examined forensically will be more likely to present with 
metastatic cancer damage to their skeleton, which would be an indication to the forensic 
anthropologist to cautiously utilize the glabella and ventral arc when determining sex. 
However, more research must be conducted to confirm this.      
Limitations 
 There were also some issues and assumptions made with the sample utilized that 
could have limited the results. The most important concern is that the duration of 
treatment for each individual was unknown. The individual could have received only a 
few chemotherapy sessions or had to undergo treatment for years. Associated with this 
concern is the timing of the treatment was also unknown. The individual could have been 
undergoing treatment when they died or received it 30 years beforehand. If the individual 
ended treatment long before they died, it is possible that the bone was able to repair itself, 
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and therefore, leave no trace of CTIBL (White et al. 2012). The cause of death could 
have been used to make assumptions about whether the individual was receiving 
treatment when they died, as many of the individuals in the drug-based treatment 
subgroup had their form of cancer listed as their cause of death. However, the possibility 
of error regarding the timing of treatment was too high to structure the analyses around 
this assumption.  
 The available antemortem data was also an issue in and of itself. For all of the 
individuals, the exact form of treatment down to the specific drug or duration of 
treatment was unknown. The general form of treatment was available for almost every 
single individual. This simply included if any treatment occurred and if it was radiation, 
chemotherapy or surgery-based. About one-third of the sample had only received surgery 
as a form of treatment. This was also a concern, as surgery is not generally known to 
cause CTIBL as severely as radiation therapy or chemotherapy (Jones 2015). These 
individuals were still included in the study, but it was an unexpected variable that had to 
be taken into consideration and may have affected the results of the analyses conducted 
on the sample as a whole.  
 Though for the purposes of this study it may not have been a detriment, the 
ancestry of the sample was highly uniform with non-European Americans representing 
only 1.7% of the total sample. Therefore, any results from this study are only relevant 
when discussing European Americans. This study could not necessarily be applied to 
other ancestry groups without further research. Another issue was that the mean age-at-
death of the total sample was 66 years old. A very large portion of the sample consisted 
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of older individuals, so these results are not representative of younger individuals who 
have undergone cancer treatment. In order to assess the possible effects of age in this 
study, the sample could only be broken down into two age groups. The younger group 
was 59 years and younger while the older group was 60 years and older. Only two groups 
were used because dividing the sample into decades would have resulted in the younger 
decades having very small sample sizes. Also 59 was chosen as the cutoff between the 
two groups to ensure that the sample sizes would be more even between the two groups.  
Conclusion 
 Almost no statistical relationship was found between cancer treatment status of 
the individual and the scores of the morphological traits analyzed in this study. In only 
two analyses was cancer treatment status determined to be statistically significant. These 
included the Chi-square analysis of the female glabella in the pooled group and the 
ANOVA analysis of the ventral arc in the surgery group. It is possible that these results 
represent a statistically significant relationship between cancer treatment status and the 
trait scores. However, it is far more likely that these results occurred due to random 
chance based on natural variation between the control group and the experimental group. 
This is the most likely scenario as the ANOVA analysis for the glabella and the Chi-
square analysis for the ventral arc did not indicate any statistically significant relationship 
between cancer treatment status and the scores for that trait. Sex was determined to be a 
statistically significant factor for every trait in all three groups for all analyses (Buikstra 
and Ubelaker 1994; Klales et al. 2012; Phenice 1969; Walker 2005; Walker 2008). This 
was expected and in line with all previously published research on the methods utilized to 
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score the traits. Age was also determined to be a significant factor for several of the traits, 
especially in the pooled group. This is also in line with previously published research on 
the subject, which indicates that age does have an effect on the scores of these traits 
(Buikstra and Ubelaker 1994; Graw et al. 1999; Garvin et al. 2014; Walker 2005).  
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CHAPTER 6: CONCLUSION 
Summary 
 Cancer is the second leading cause of death in the U.S., and approximately 
1,688,780 new cases of cancer are expected to be diagnosed this year alone (American 
Cancer Society 2017). It is a pervasive disease that is becoming more common in the 
later years of life but can still affect anyone at any age. With this growth in cancer a 
similar rise has occurred in cancer research. Cancer treatments are rapidly advancing and 
becoming more available. The most common forms of cancer treatment are radiation, 
chemotherapy, and surgery (Jones 2015). All of these treatments involve an array of side 
effects when used long-term, but one of the most pervasive and damaging side effects is 
CTIBL. Cancer treatment-induced bone loss refers to a general loss of BMD, similar to 
osteoporosis and osteopenia. Cancer treatment-induced bone loss occurs when the cancer 
treatment either directly or indirectly affects normal bone metabolism by decreasing 
osteoblastic or bone forming activity and increasing osteoclastic or bone resorption 
activity. The most common cause of CTIBL occurs when the cancer treatment damages 
the ovaries or testes, resulting in hypogonadism. Hypogonadism refers to an extensive 
decrease in gonadal hormones, especially estrogen. Gonadal hormones are known to be 
important in the regulation of osteoblast formation, which in turn regulates osteoclast 
formation. The decrease in estrogen results in an increase in osteoclast formation. This 
results in a net loss of bone or CTIBL (Coleman et al. 2013; D’Oronzo et al. 2015; 
Michaud and Goodin 2006).  
 As cancer rates and cancer survival rates continue to rise, it is vital to understand 
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how the long-term side effects of the disease process and their treatments affect the 
human skeleton in a forensic context. Many of the standard techniques utilized in forensic 
anthropology rely on the assessment of the size and shape of specific morphological 
traits. Sex is a crucial part of the biological profile that, when attempting to identify an 
individual, can narrow the potential list by approximately half. The scoring of sexually 
dimorphic morphological traits on different skeletal elements is one of the most widely 
utilized techniques to determine sex in forensic anthropology (Graw et al. 1999; Pinto et 
al. 2016). It is a subjective method that relies heavily on the experience of the observer. 
However, it requires no special equipment nor an extensive amount of time to conduct 
(Walker 2008). The os coxa and the skull are believed to be the two most sexually 
dimorphic elements of the human skeleton (Graw et al. 1999; Pinto et al. 2016). 
However, some have argued that the skull is not as accurate as metric analyses of the 
postcrania (Spradley and Jantz 2011). However, morphological examinations of the skull 
are still widely utilized in forensic anthropology and were included in this study.  
 All of the commonly used techniques that assess morphological sex rely on the 
size and shape of certain traits to determine sex. However, individuals who have 
undergone cancer treatment are likely to eventually present with CTIBL resulting in a 
loss of bone. It is possible that this loss in bone can affect the size and shape of the 
morphological traits used to determine sex. The possible effects of CTIBL on these 
commonly assessed traits must be understood so as to avoid the misclassification of 
individuals who present with signs of cancer and/or CTIBL. It was hypothesized that 
CTIBL decreases the robusticity of sexually dimorphic visually assessed, and will 
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therefore, skew sex assessment towards more gracile scores for the individual.  
 In order to test the asserted hypotheses, a sample of 356 individuals were obtained 
from the William M. Bass Donated Skeletal Collection housed at the University of 
Tennessee, Knoxville. A total of 178 of these individuals had some history of cancer in 
their antemortem data, which included the general form of treatment. This group was 
then further subdivided into individuals who had received chemotherapy and/or radiation 
as their form of treatment versus individuals who had only received surgery as their form 
of treatment. This division was made as CTIBL is a less common side effect of surgery as 
a form of cancer treatment. The other 178 individuals in the sample were designated as a 
control group. These individuals had no history of cancer and were chosen from a 
provided list to parallel the demographics of the experimental group including age, sex, 
and ancestry. Those who had “natural” listed as their cause of death were chosen to 
eliminate any possible confounding variables in the data. However, it is possible that 
some of these individuals had cancer before death or at the time of death, as the records 
may not be highly accurate or up to date.   
 The entire sample was randomized so that the analysis could be conducted 
blindly. The left os coxa and the skull were scored utilizing standard techniques for sex 
assessment. The methods of Klales et al. (2012), Walker (2005), and Buikstra and 
Ubelaker (1994) were employed for the os coxa, and the methods of Walker (2008) were 
utilized to score the skull. These methods resulted in the scoring of 10 traits for each 
individual that included the ventral arc, subpubic contour, ischiopubic ramus ridge, 
greater sciatic notch, preauricular sulcus, nuchal crest, mastoid process, supraorbital 
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margin, glabella, and mental eminence. During the statistical analyses the pre-auricular 
sulcus was excluded as the ordinal scores for this trait differ in their meaning compared 
to the other nine traits.  
 As the methods utilized in this study are subjective, intraobserver agreement was 
also assessed. Ten percent (n=?) of the total sample was randomly selected and rescored 
using the same methods. The original scores of the traits were then compared to the 
rescored traits using a Cohen’s Kappa analysis. This analysis produced kappa values 
ranging from -1 to +1. The higher kappa values indicated higher intraobserver agreement. 
Four of the nine traits had moderate intraobserver agreement, four of the nine traits had 
substantial intraobserver agreement, and one trait had only fair intraobserver agreement. 
These results indicate that intraobserver agreement was decent, with most traits resulting 
in either moderate or substantial intraobserver agreement. This implied that the observer 
was consistent in their scoring, and therefore, the results of the subsequent analyses could 
be considered reliable which limits intraobserver variability.  
 Once the traits were scored for every individual, Chi-square, ANOVA, and 
ANCOVA analyses were conducted to determine if there was a statistically significant 
relationship between the cancer treatment status of the individual and the scores of the 
sexually dimorphic traits. Sex and age were also analyzed to determine their significance 
with the trait scores. Sex was determined to be statistically significant at the 0.00 level for 
every trait. This was expected as it has been demonstrated in numerous previous studies 
(Buikstra and Ubelaker 1994; Graw et al. 1999; Klales et al. 2012; Phenice 1969; Walker 
2005; Walker 2008). Age was also determined to be statistically significant in several of 
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the traits both in the pooled group and in the drug subgroup. These traits included the 
subpubic contour, ischiopubic ramus ridge, nuchal crest, and mastoid process for the 
pooled group. Age for the ischiopubic ramus ridge and the mastoid process were 
statistically significant in the drug subgroup.  
 Only two analyses concluded that cancer treatment status had a statistically 
significant relationship with the trait scores. A Chi-square analysis concluded that cancer 
treatment status was slightly significant for the glabella of females in the pooled group 
with a p-value of 0.047. An ANOVA analysis determined that cancer treatment status 
was highly significant for the ventral arc in the surgery subgroup with a p-value of 0.010 
when cancer treatment status was considered independently of sex. There were also three 
other ANOVA analyses that were very close to being statistically significant. They 
included cancer treatment status alone for the ventral arc of the drug subgroup, the 
glabella of the pooled group and the nuchal crest of the surgery subgroup. This is 
important to note as the glabella and ventral arc were the two traits that were found to 
have significant relationships between cancer treatment status and the trait scores.  
Implications 
 These results indicate that for the glabella and the ventral arc there is a possible 
connection between the cancer treatment status of the individual and the scores of that 
trait. Therefore, CTIBL may slightly skew these trait scores. If this is true, it may be 
necessary to cautiously use the glabella and the ventral arc from individuals that present 
with any signs of cancer or extensive bone loss that could be attributed to cancer 
treatment. This is important in the forensic setting as cancer has been documented in a 
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large portion of the population and the number of cancer diagnoses is continuing to rise. 
Further, as treatments improve there is a connected rise in cancer survival. According to 
the American Cancer Society (2017), 68% of European Americans are surviving at least 
five years past diagnosis. Therefore, more individuals are surviving longer, which means 
they are undergoing treatment longer, possibly resulting in the presence of more long-
term side effects such as CTIBL. As these side effects become more common in cancer 
survivors, it is important to understand how this may affect their skeleton in a forensic 
context. Based on this research, it is possible that the glabella and ventral arc of these 
individuals could be misleading in terms of sex.  
 It is absolutely possible that the ventral arc and the glabella are less diagnostic of 
sex in individuals with CTIBL based on the results of the statistical analyses. However, it 
is far more likely that the results occurred due to random chance as opposed to actual 
statistical significance. It is far more likely that these results were produced due to natural 
variation between the control and experimental groups, and that by chance one group was 
more robust or gracile than the other group. This could have led the analyses to indicate 
that the cancer treatment status of the individual was significant when it was simply 
natural variation between the two groups. This is supported by the fact that the ANOVA 
analyses for the glabella and the Chi-square analyses for the ventral arc did not produce 
any significant results. If the significant results were indicative of an actual relationship 
then the subsequent Chi-square or ANOVA analyses should have resulted in a statistical 
significance as well. Random chance is also the more likely reason for the results as there 
is no trend based on sex. The ventral arc was only significant in the surgery group when 
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sex wasn’t a factor and the glabella was only significant for females in the pooled sample. 
Further, it is unlikely that surgery as a form of treatment would lead to such severe 
CTIBL that it affected the scores of the ventral arc.    
Future Research 
 Based on this research, there is not enough evidence to support a connection 
between the presence of CTIBL and the scores of the sexually dimorphic traits utilized in 
the assessment of sex. Cancer treatment-induced bone loss does not decrease the 
robusticity of sexually dimorphic traits and therefore, does not skew sex assessment 
towards gracile in individuals with a history of cancer. This implies that if a set of 
remains is found that presents with indications of cancer or extensive bone loss that could 
be associated with cancer treatment, the forensic anthropologist does not need to take this 
history into account when assessing the sex of the individual using visually assessed, 
sexually dimorphic traits. 
 The U.S. is becoming an over-prescribed and drug dependent society (Stimmel 
1985), and it is important that future research consider the possible effects to the skeleton 
from long-term use of medications, drugs, and treatments. There are many different 
medications and treatments that are known to affect human skeletal anatomy. These 
include medications such as glucocorticoids, antiepileptics, heparin, immunosuppresants, 
diabetes medications, and many more (Chandran 2017; Hudec and Camacho 2013). 
These medications are commonly used long term and often result in an extensive 
reduction of BMD (Hudec and Camacho 2013). However, almost no research has been 
conducted on how these medications and drugs may affect human skeletal anatomy, and 
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therefore, the standard techniques utilized in forensic anthropology to develop the 
biological profile. What research has been conducted has focused on substance abuse and 
its effects on age estimation. For example, Taylor (2000) conducted her dissertation on 
the effects of heroin, cocaine, alcohol, and intravenous drugs on the assessment of age-at-
death from the sternal end of the 4th rib. Hartnett (2007) found that a history of substance 
abuse did not affect age-at-death estimations using the pubic symphysis or the sternal end 
of the 4th rib in any statistically significant way. However, she did note that based on her 
personal observations, when an individual was greatly misclassified they often had a 
history of substance abuse. This lends some credence to Taylor’s (2000) work.  
 Based on what little research has been conducted, it is clear that medications and 
drugs can have some effect on the skeletal system and could therefore impact the 
techniques utilized by forensic anthropologists. This research focused specifically on 
cancer treatments and the possible effects on morphological sex assessment. No 
statistically significant relationship was found between cancer treatment status and the 
scoring of the morphological traits. However, this research should be extended into other 
components of the biological profile and considered in any metric techniques to estimate 
sex. This research should especially be expanded into age-at-death as a component of the 
biological profile. Other previous studies have concluded that drugs can have an effect on 
some of the age-at-death estimation techniques utilized in forensic anthropology (Hartnett 
2007; Taylor 2000). Therefore, it is possible that CTIBL could also affect these age-at-
death estimation techniques. Ancestry and stature should also be considered as areas of 
future research to ensure that no part of the biological profile is being overlooked. 
  
  
76 
 This research should also be extended to other types of medications that are 
known to have an effect on human skeletal anatomy. There are many other types of 
medications that can result in medication-induced osteoporosis resulting from an 
extensive decrease in BMD. It is important to understand how all of these medications, 
which are becoming increasingly common and over-prescribed, can affect the standard 
techniques utilized in the biological profile. Many of these medications are also used to 
treat multiple illnesses. For example, methotrexate and cyclophosphamide are common 
medications used in chemotherapy. They are also medications commonly used to treat 
Lupus, which is a disease that results in tissue damage from inflammation and antibody 
production (Wallace 2008). Basing future research on the specific types of medication as 
opposed to the disease it is meant to treat may increase sample sizes and provide a more 
specific understanding of the effects of these medications on the biological profile.  
 Sex is one of the most crucial components of the biological profile as the 
assessment of sex can very quickly narrow the scope of a forensic investigation. The 
visual assessment of sexually dimorphic morphological traits is the basis for most of the 
commonly utilized methods in forensic anthropology to determine sex. Therefore, it is 
crucial to understand the factors that could potentially affect the trait expressions. Cancer 
is currently the second leading cause of death in the U.S., and one of the most pervasive 
side effects of cancer treatment is CTIBL. This net bone loss is a common side effect that 
affects all individuals that undergo long-term chemotherapy and radiation-based cancer 
treatments. This study was designed to evaluate whether CTIBL affected the morphology 
of the sexually dimorphic traits commonly utilized to determine sex. Based on the results 
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of this research, CTIBL does not affect these morphological traits. However, expanding 
this research to other parts of the biological profile and to different medications that are 
known to cause bone loss would be invaluable to understanding all possible confounders 
to the biological profile in a modern, forensic setting.  
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